<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">TDE</journal-id>
<journal-id journal-id-type="hwp">sptde</journal-id>
<journal-id journal-id-type="nlm-ta">Diabetes Educ</journal-id>
<journal-title>The Diabetes Educator</journal-title>
<issn pub-type="ppub">0145-7217</issn>
<issn pub-type="epub">1554-6063</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0145721712464400</article-id>
<article-id pub-id-type="publisher-id">10.1177_0145721712464400</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Features</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Facilitating Healthy Coping in Patients With Diabetes</article-title>
<subtitle>A Systematic Review</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Thorpe</surname><given-names>Carolyn T.</given-names></name>
<degrees>PhD, MPH</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Fahey</surname><given-names>Lauren E.</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Johnson</surname><given-names>Heather</given-names></name>
<degrees>MD, MS</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Deshpande</surname><given-names>Maithili</given-names></name>
</contrib>
<contrib contrib-type="author">
<name><surname>Thorpe</surname><given-names>Joshua M.</given-names></name>
<degrees>PhD, MPH</degrees>
</contrib>
<contrib contrib-type="author">
<name><surname>Fisher</surname><given-names>Edwin B.</given-names></name>
<degrees>PhD</degrees>
</contrib>
</contrib-group>
<aff id="aff1-0145721712464400">Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania (Dr C. Thorpe, Dr J. Thorpe)</aff>
<aff id="aff2-0145721712464400">University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania (Dr C. Thorpe, Dr J. Thorpe)</aff>
<aff id="aff3-0145721712464400">Department of Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin (Ms Fahey)</aff>
<aff id="aff4-0145721712464400">Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin (Dr Johnson)</aff>
<aff id="aff5-0145721712464400">University of Wisconsin School of Pharmacy, Madison, Wisconsin (Ms Deshpande)</aff>
<aff id="aff6-0145721712464400">University of North Carolina School of Public Health, Chapel Hill, North Carolina (Dr Fisher)</aff>
<author-notes>
<corresp id="corresp1-0145721712464400">Carolyn T. Thorpe, PhD, MPH, Department of Pharmacy &amp; Therapeutics, School of Pharmacy, University of Pittsburgh, 919 Salk Hall, 3501 Terrace Street, Pittsburgh, PA, 15261 (<email>ctthorpe@pitt.edu</email>).</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>1</month>
<year>2013</year>
</pub-date>
<volume>39</volume>
<issue>1</issue>
<fpage>33</fpage>
<lpage>52</lpage>
<permissions>
<copyright-statement>© 2013 The Author(s)</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">American Association of Diabetes Educators; Published by SAGE Publications</copyright-holder>
</permissions>
<abstract>
<sec id="section1-0145721712464400">
<title>Purpose</title>
<p>The purpose of this study is to summarize recent literature on approaches to supporting healthy coping in diabetes in 2 specific areas: (1) the impact of different approaches to diabetes treatment on healthy coping and (2) the effectiveness of interventions specifically designed to support healthy coping.</p>
</sec>
<sec id="section2-0145721712464400">
<title>Methods</title>
<p>A PubMed search identified 129 articles published August 1, 2006, to April 30, 2011, addressing diabetes in relation to emotion, quality of life, depression, adjustment, anxiety, coping, family therapy, behavior therapy, psychotherapy, problem solving, couples therapy, or marital therapy.</p>
</sec>
<sec id="section3-0145721712464400">
<title>Results</title>
<p>Evidence suggests that treatment choice may significantly influence quality of life, with treatment intensification in response to poor metabolic control often improving quality of life. The recent literature provides support for a variety of healthy coping interventions in diverse populations, including diabetes self-management education, support groups, problem-solving approaches, and coping skills interventions for improving a range of outcomes; cognitive behavior therapy and collaborative care for treating depression; and family therapy for improving coping in youths.</p>
</sec>
<sec id="section4-0145721712464400">
<title>Conclusions</title>
<p>Healthy coping in diabetes has received substantial attention in the past 5 years. A variety of approaches show positive results. Research is needed to compare the effectiveness of different approaches in different populations and determine how to overcome barriers to intervention dissemination and implementation.</p>
</sec>
</abstract>
<custom-meta-wrap>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January/February 2013</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>In recognition of the wide range of coping challenges presented by diabetes across genetic, behavioral, family, social, community, organizational, and political contexts, the American Association of Diabetes Educators (AADE) has identified healthy coping as one of the key AADE7™ Self-Care Behaviors and defined it as the following:
<disp-quote>
<p>Health status and quality of life are affected by psychological and social factors. Psychological distress directly affects health and indirectly influences a person’s motivation to keep their diabetes in control. When motivation is dampened, the commitments required for effective self-care are difficult to maintain. When barriers seem insurmountable, good intentions alone cannot sustain the behavior. Coping becomes difficult and a person’s ability to self-manage their diabetes deteriorates.</p>
</disp-quote></p>
<p>From this definition, it is clear that the construct of “healthy coping” includes a number of related but distinct domains of psychosocial outcomes. In addition to avoiding specific psychological problems such as depressive and anxiety disorders, high levels of perceived stress and other negative emotions, and diabetes-specific distress, healthy coping also involves positive attitudes toward diabetes and its treatment, positive relationships with others, and high perceived health-related quality of life (QOL). That is, healthy coping extends beyond the mere avoidance of psychiatric morbidity to encompass high levels of psychosocial functioning and a positive outlook on the illness and overall QOL. <xref ref-type="table" rid="table1-0145721712464400">Table 1</xref> provides more detail on specific healthy coping domains that are commonly examined in the diabetes literature.</p>
<table-wrap id="table1-0145721712464400" position="float">
<label>Table 1</label>
<caption>
<p>Domains of Healthy Coping</p>
</caption>
<graphic alternate-form-of="table1-0145721712464400" xlink:href="10.1177_0145721712464400-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Domain</th>
<th align="center">Description</th>
</tr>
</thead>
<tbody>
<tr>
<td>Depression</td>
<td>Disorder of mood characterized by feelings of sadness or emptiness, reduced interest in activities, sleep disturbances, loss of energy, difficulty concentrating or making decisions<sup><xref ref-type="bibr" rid="bibr83-0145721712464400">83</xref></sup></td>
</tr>
<tr>
<td>Anxiety disorder</td>
<td>Disorders characterized by abnormal or inappropriate symptoms of anxiety (eg, increased heart rate, tensed muscles, intense worry), such as generalized anxiety disorder or panic disorder<sup><xref ref-type="bibr" rid="bibr83-0145721712464400">83</xref></sup></td>
</tr>
<tr>
<td>Perceived stress</td>
<td>Degree to which individuals perceive different aspects of their lives as unpredictable, uncontrollable, and overwhelming<sup><xref ref-type="bibr" rid="bibr84-0145721712464400">84</xref></sup></td>
</tr>
<tr>
<td>Diabetes-specific distress</td>
<td>Negative emotional responses and perceived burden related to diabetes<sup><xref ref-type="bibr" rid="bibr85-0145721712464400">85</xref>,<xref ref-type="bibr" rid="bibr86-0145721712464400">86</xref></sup></td>
</tr>
<tr>
<td>Positive attitudes and beliefs about the illness and treatment</td>
<td>Psychological adjustment to diabetes<sup><xref ref-type="bibr" rid="bibr87-0145721712464400">87</xref></sup>; treatment satisfaction<sup><xref ref-type="bibr" rid="bibr88-0145721712464400">88</xref></sup></td>
</tr>
<tr>
<td>Positive relationships with others</td>
<td>High perceptions of general and diabetes-specific social support; family functioning</td>
</tr>
<tr>
<td>Health-related quality of life</td>
<td>Subjective evaluation of overall physical, mental, and social health and functioning</td>
</tr>
</tbody>
</table></table-wrap>
<p>As awareness of the interrelationships between diabetes, its management, and these outcomes has grown, interest in intervening to facilitate healthy coping in diabetic patients has also expanded. The purpose of this article is to systematically review literature on healthy coping in diabetes published in the past 5 years, with a focus on identifying evidence for effective interventions that has emerged since a prior review.<sup><xref ref-type="bibr" rid="bibr1-0145721712464400">1</xref></sup> Two questions within this broad topic area are addressed: How do different diabetes treatment approaches affect healthy coping outcomes? How do different interventions designed to improve healthy coping affect psychosocial and QOL outcomes?</p>
<sec id="section5-0145721712464400" sec-type="methods">
<title>Methods</title>
<sec id="section6-0145721712464400">
<title>Search</title>
<p>Parallel with the multiple domains of healthy coping, intervention approaches for addressing concerns in diabetic patients across the life span are diverse, and there are relatively few well-controlled studies of any single intervention approach. Thus, this review was designed to provide a broad appraisal of promising approaches for addressing an array of healthy coping issues. The review used systematic review procedures in specifying the terms and approach to searching for and abstracting data from articles but used narrative procedures in including articles without a priori criteria based on methods and design.</p>
<p>A PubMed search of the English-language literature published between August 1, 2006, and April 30, 2011, was performed. Combinations of <italic>diabetes</italic> with the terms <italic>emotion, quality of life, depression, adjustment, anxiety, anxious, coping, family therapy, behavior therapy, psychotherapy, problem solving, couples therapy</italic>, or <italic>marital therapy</italic> were used to identify relevant studies. <xref ref-type="fig" rid="fig1-0145721712464400">Figure 1</xref> provides details on search procedures and results.</p>
<fig id="fig1-0145721712464400" position="float">
<label>Figure 1.</label>
<caption>
<p>Outline of search of healthy coping in diabetes management, 2006 to 2011.</p>
</caption>
<graphic xlink:href="10.1177_0145721712464400-fig1.tif"/></fig>
</sec>
<sec id="section7-0145721712464400">
<title>Study Selection</title>
<p>Titles and abstracts of articles meeting the above search criteria were reviewed as candidates for data abstraction. To be included in the final review, articles needed to report the effects of either a diabetes treatment or healthy coping intervention on at least 1 psychosocial or QOL outcome. Retrospective and prospective studies were included, along with narrative or systematic review articles. All articles pertaining to type 1 diabetes (T1DM) or type 2 diabetes (T2DM) were included, and there were no restrictions with regard to patient age. Articles aimed at lay audiences, statements of opinion, or descriptions of programs with no research component were excluded.</p>
</sec>
<sec id="section8-0145721712464400">
<title>Data Abstraction</title>
<p>Articles meeting criteria were grouped into the 2 main questions targeted for review: (1) evidence describing the impact of diabetes treatments on healthy coping constructs and (2) interventions to promote healthy coping. Articles were then further categorized according to intervention type (see <xref ref-type="fig" rid="fig1-0145721712464400">Figure 1</xref>), abstracted independently by the authors, and incorporated into the Healthy Coping Evidence Table (available as an online appendix). Abstracted data elements included study design, original research versus review of published studies, study objectives, sample size, healthy coping outcomes assessed, other outcomes assessed (eg, A1C), and principal findings, including both significant and nonsignificant results. For all studies, the American Association of Clinical Endocrinologists (AACE) evidence ratings<sup><xref ref-type="bibr" rid="bibr2-0145721712464400">2</xref></sup> corresponding to the study designs were also determined.</p>
</sec>
<sec id="section9-0145721712464400">
<title>Study Characteristics</title>
<p>As shown in <xref ref-type="fig" rid="fig1-0145721712464400">Figure 1</xref>, 129 articles met criteria for inclusion, including 59 articles examining the effect of diabetes treatments on healthy coping domains and 70 articles examining the efficacy or effectiveness of interventions specifically designed to promote healthy coping. Cognitive behavior therapy, family therapy, diabetes self-management education, and primary care-based approaches were the most common intervention types; fewer articles were identified that focused on problem solving and coping skills, support groups or group counseling, and medication for psychological problems.</p>
</sec>
<sec id="section10-0145721712464400">
<title>Data Synthesis</title>
<p>The evidence table describing studies within the 2 broad areas relevant to healthy coping in diabetes drove the organization of the narrative review accordingly: (1) effect of diabetes treatments on QOL and psychosocial outcomes and (2) evidence for the efficacy or effectiveness of healthy coping interventions in improving QOL and other psychosocial outcomes. Results summarized in the text below focus on articles reporting original research, with <xref ref-type="table" rid="table2-0145721712464400">Tables 2</xref> and <xref ref-type="table" rid="table3-0145721712464400">3</xref> providing additional detail in 2 areas. <xref ref-type="table" rid="table2-0145721712464400">Table 2</xref> summarizes the large number of studies that examined the psychosocial and QOL effects of different methods of intensifying treatment in poorly controlled diabetes, whereas <xref ref-type="table" rid="table3-0145721712464400">Table 3</xref> summarizes original intervention research studies identified in the review. The complete Healthy Coping Evidence Table is available as an online appendix.</p><table-wrap id="table2-0145721712464400" position="float">
<label>Table 2</label>
<caption>
<p>Key Studies on the Effects of Treatment Intensification With Different Types of Therapies and Regimens in Adults With Type 2 Diabetes</p>
</caption>
<graphic alternate-form-of="table2-0145721712464400" xlink:href="10.1177_0145721712464400-table2.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Reference</th>
<th align="center">Study Objectives and Methods</th>
<th align="center">Study Design</th>
<th align="center">Sample Size</th>
<th align="center">Findings</th>
</tr>
</thead>
<tbody>
<tr>
<td>Best et al 2011<sup><xref ref-type="bibr" rid="bibr26-0145721712464400">26</xref></sup></td>
<td>Compare once-weekly injections with exenatide to 2 different classes of OHAs (sitagliptin or pioglitazone) with regard to effects on QOL and psychological and clinical outcomes.</td>
<td>Randomized, double-blind, double-dummy, multicenter clinical trial; poorly controlled adults with type 2 diabetes on metformin randomized to exenatide (GLP-4 injectable) once weekly plus placebo oral capsule each morning, sitagliptin plus placebo once-weekly injection, or pioglitazone plus placebo once-weekly injection.</td>
<td>N = 491</td>
<td>Addition of any of the 3 medications improved QOL and psychological outcomes. Greater improvements in weight-related QOL, general health utility, and treatment satisfaction were observed for exenatide once-weekly compared with one or both of the other treatments.</td>
</tr>
<tr>
<td>Peyrot et al 2008<sup><xref ref-type="bibr" rid="bibr27-0145721712464400">27</xref></sup></td>
<td>Compare diabetes-related distress and clinical outcomes in type 2 diabetic patients using insulin with or without mealtime pramlintide (an amylin analog)</td>
<td>Randomized, double-blind, placebo-controlled study; type 2 patients using insulin glargine with or without OHAs were randomized to pramlintide or placebo.</td>
<td>N = 211</td>
<td>Pramlintide use resulted in decreases in total diabetes-related distress and regimen-related distress in those who were highly distressed at baseline.</td>
</tr>
<tr>
<td>Peyrot et al 2010<sup><xref ref-type="bibr" rid="bibr28-0145721712464400">28</xref></sup></td>
<td>Assess effect of adding mealtime pramlintide or RAIA to basal insulin therapy in patients with uncontrolled type 2 diabetes.</td>
<td>Open-label, randomized, parallel group trial, stratified with regard to use of basal insulin prior to study enrollment.</td>
<td>N = 112</td>
<td>Adding either pramlintide or RAIA at mealtime to basal insulin improved treatment satisfaction. Pramlintide also reduced diabetes distress and improved sleep quality, weight control, and appetite control; RAIA improved eating flexibility and perceived weight control.</td>
</tr>
<tr>
<td>Bode et al 2010<sup><xref ref-type="bibr" rid="bibr29-0145721712464400">29</xref></sup></td>
<td>Compare effect of adding a GLP-1 once-daily medication (liraglutide) vs an OHA (glimepiride) to treatment regimen.</td>
<td>Randomized, double-blind, double-dummy, parallel-group, multicenter clinical trial; patients stratified by initial treatment with a single OHA vs diet and exercise only and randomized to once-daily treatment with once-daily liraglutide (GLP-1) 1.2 mg or 1.8 mg or glimepiride (sulfonylurea).</td>
<td>N = 732</td>
<td>Liraglutide produced more favorable improvements in health-related QOL and weight concerns compared with glimepiride, with much stronger effects at the higher dosage of 1.8 mg.</td>
</tr>
<tr>
<td>Ushakova et al 2007<sup><xref ref-type="bibr" rid="bibr30-0145721712464400">30</xref></sup></td>
<td>Compare glycemic control, weight gain, tolerability, and treatment satisfaction and QOL for 3 different regimens in insulin-naïve uncontrolled type 2 diabetic patients: (1) biphasic insulin aspart 30 alone, (2) biphasic insulin aspart 30 + metformin, and (3) OHA therapy alone.</td>
<td>Randomized, open-label, parallel-group, multicenter trial.</td>
<td>N = 308</td>
<td>The insulin regimens improved QOL and treatment satisfaction similarly to a multiple drug oral regimen.</td>
</tr>
<tr>
<td>Lingvay et al 2009<sup><xref ref-type="bibr" rid="bibr31-0145721712464400">31</xref></sup></td>
<td>Compare triple therapy with OHA (metformin, pioglitazone, and glyburide) to twice-daily insulin plus metformin in newly diagnosed, adult type 2 diabetic patients.</td>
<td>Open-label, randomized controlled trial.</td>
<td>N = 29</td>
<td>There were no group differences in hypoglycemic events, weight gain, adherence, or changes in QOL, and social worries improved over time in both groups. All patients assigned to insulin reported satisfaction with insulin treatment and willingness to continue at 18 months follow-up.</td>
</tr>
<tr>
<td>Houlden et al 2007<sup><xref ref-type="bibr" rid="bibr32-0145721712464400">32</xref></sup></td>
<td>Assess effect of insulin glargine (basal insulin) initiation with no change in OHA therapy vs optimization of OHA therapy on QOL.</td>
<td>Randomized, controlled trial of adults aged 18-80 with type 2 diabetes and inadequate glucose control taking 0, 1, or 2 OHAs.</td>
<td>N = 366</td>
<td>Addition of insulin glargine vs more OHAs had greater positive impact on treatment satisfaction and QOL.</td>
</tr>
<tr>
<td>Vinik and Zhang 2007<sup><xref ref-type="bibr" rid="bibr33-0145721712464400">33</xref></sup></td>
<td>Compare effect of add-on insulin glargine vs rosiglitazone on health-related QOL in patients with type 2 diabetes already taking a sulfonylurea plus metformin.</td>
<td>24-week, multicenter, randomized, open-label, parallel-group trial.</td>
<td>N = 217</td>
<td>Symptom distress, mood symptoms, ophthalmologic distress, fatigue distress, and general self-rated health improved more for the insulin glargine group. Adverse events were also less frequent in the insulin glargine group.</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0145721712464400"><p>Abbreviations: GLP, glucagon-like peptide; OHA, oral hypoglycemic agent; QOL, quality of life; RAIA, rapid-acting insulin analog.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="table3-0145721712464400" position="float">
<label>Table 3</label>
<caption>
<p>Summaries of Key Intervention Articles</p>
</caption>
<graphic alternate-form-of="table3-0145721712464400" xlink:href="10.1177_0145721712464400-table3.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Reference</th>
<th align="center">Study Objectives and Methods</th>
<th align="center">Study Design</th>
<th align="center">Sample Size</th>
<th align="center">Findings</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="5"><bold>Diabetes Self-Management Education</bold></td>
</tr>
<tr>
<td> Speight et al 2010<sup><xref ref-type="bibr" rid="bibr42-0145721712464400">42</xref></sup></td>
<td>Evaluate long-term (44-month follow-up) outcomes of DAFNE, a structured education program in intensive insulin therapy for adults with poorly controlled type 1 diabetes.</td>
<td>Observational cohort study of all participants who were originally randomized to receive DAFNE immediately vs after a 6-month wait list.</td>
<td>N = 104</td>
<td>Improvements in QOL seen at 12-month follow-up were sustained at 44-month follow-up. Improvements in treatment satisfaction at 12-month follow-up decreased significantly at 44 months but remained meaningfully higher than baseline levels.</td>
</tr>
<tr>
<td> Kempf et al 2010<sup><xref ref-type="bibr" rid="bibr43-0145721712464400">43</xref></sup></td>
<td>Evaluate ROSSO-in-praxi, a structured 12-week motivation and education program focused on self-monitoring of blood glucose in 405 adults with type 2 diabetes.</td>
<td>Pre–post within-group comparison.</td>
<td>N = 405</td>
<td>Mental health and depressive symptoms improved from pre-intervention to post-intervention.</td>
</tr>
<tr>
<td> Rossi et al 2010<sup><xref ref-type="bibr" rid="bibr41-0145721712464400">41</xref></sup></td>
<td>Compare use of a DID to a structured carbohydrate-counting education program.</td>
<td>Open-label, international, multicenter, randomized parallel-group trial; adults with type 1 diabetes were randomly assigned to DID vs carbohydrate-counting education.</td>
<td>N = 130</td>
<td>The DID group experienced greater improvements in treatment satisfaction and QOL, including greater dietary freedom, and duration of education required was lower.</td>
</tr>
<tr>
<td> Bendik et al 2009<sup><xref ref-type="bibr" rid="bibr40-0145721712464400">40</xref></sup></td>
<td>Evaluate training in flexible insulin therapy on psychological and metabolic outcomes in type 1 diabetic patients; intervention consisted of 7 weekly group sessions.</td>
<td>Pre–post within-group comparison of type 1 diabetic patients.</td>
<td>N = 45</td>
<td>QOL, self-control, and diabetes knowledge all improved significantly.</td>
</tr>
<tr>
<td> Utz et al 2008<sup><xref ref-type="bibr" rid="bibr89-0145721712464400">89</xref></sup></td>
<td>Compare group vs individual culturally tailored diabetes self-management education in rural African Americans with type 2 diabetes.</td>
<td>Randomized trial; patients assigned to group or individual DSME/T.</td>
<td>N = 22</td>
<td>There was a nonsignificant trend for greater improvements in empowerment, goal attainment, diet, and foot care for group DSME/T. Both group and individual DSME/T improved goal attainment and self-care.</td>
</tr>
<tr>
<td> Lowe et al 2008<sup><xref ref-type="bibr" rid="bibr39-0145721712464400">39</xref></sup></td>
<td>Evaluate intensive insulin management to help type 1 and type 2 diabetic patients match insulin dose to carbohydrate intake‥</td>
<td>Pre–post within-group comparison; patients with type 1 diabetes and type 2 diabetes assessed at 4 months and 12 months.</td>
<td>N = 137</td>
<td>The program improved diabetes-related QOL and problem-solving skills.</td>
</tr>
<tr>
<td> Nansel et al 2007<sup><xref ref-type="bibr" rid="bibr45-0145721712464400">45</xref></sup></td>
<td>Assess outcomes of a diabetes self-management education using a “diabetes personal trainer” (ie, trained nonprofessionals) in youth with type 1 diabetes.</td>
<td>Randomized, controlled trial; adolescents with type 1 diabetes assigned to personal trainer intervention or usual care.</td>
<td>N = 81</td>
<td>There was no significant effect of the personal trainer intervention on QOL or adherence.</td>
</tr>
<tr>
<td> Tang et al 2010<sup><xref ref-type="bibr" rid="bibr46-0145721712464400">46</xref></sup></td>
<td>Evaluate a empowerment-based diabetes self-management support intervention delivered in a weekly group format.</td>
<td>Control-intervention time series design; African Americans with type 2 diabetes first participated in a 6-month control period with weekly educational newsletters and then a 6-month intervention.</td>
<td>N = 77</td>
<td>No effect of the intervention was observed for diabetes-specific QOL, empowerment, or adherence.</td>
</tr>
<tr>
<td> Bastiaens et al 2009<sup><xref ref-type="bibr" rid="bibr44-0145721712464400">44</xref></sup></td>
<td>Implement and evaluate a group self-management education program in primary care for adults with type 2 diabetes.</td>
<td>Pilot study; pre–post within-group comparison.</td>
<td>N = 44</td>
<td>Diabetes-related emotional distress was reduced at 12 months post-intervention, but this improvement was not sustained at 18-month follow-up.</td>
</tr>
<tr>
<td colspan="5"><bold>Support Groups and Group Counseling</bold></td>
</tr>
<tr>
<td> Chaveepojnkamjorn et al 2009<sup><xref ref-type="bibr" rid="bibr47-0145721712464400">47</xref></sup></td>
<td>Evaluate a 16-week self-help group program for adults with type 2 diabetes; intervention focused on building good relationships, diabetes self-management knowledge and skill, self-monitoring, motivation in self-care, sharing experiences among group members, and improvement of training skills for group leaders as well as group structure.</td>
<td>Multicenter randomized, controlled trial; adult patients at 7 health care centers in Thailand assigned to self-help group program or control group receiving diabetes services.</td>
<td>N = 146</td>
<td>All 4 domains of QOL that were assessed (physical health, psychological, social relationships, and environment) improved in the self-help group compared with the control group at 12-week and 24-week follow-up.</td>
</tr>
<tr>
<td> Heisler et al 2010<sup><xref ref-type="bibr" rid="bibr48-0145721712464400">48</xref></sup></td>
<td>Compare a RPS program with supplemental group sessions to NCM plus 1.5-hour education session in older male veterans with poorly controlled diabetes</td>
<td>Randomized controlled trial; patients assigned to RPS or NCM.</td>
<td>N = 244</td>
<td>Perceived diabetes social support improved significantly more in the RPS group compared with NCM, and more RPS patients initiated insulin therapy. No significant differences in diabetes-specific distress.</td>
</tr>
<tr>
<td> Comellas et al 2010<sup><xref ref-type="bibr" rid="bibr49-0145721712464400">49</xref></sup></td>
<td>Evaluate peer-led community discussion circles integrating self-management support with discussion of information and skills through storytelling and exercises.</td>
<td>Pre–post within-group comparison of urban, minority adults with diabetes.</td>
<td>N = 17</td>
<td>Improved some aspects of well-being, including feeling more active and vigorous at program completion.</td>
</tr>
<tr>
<td colspan="5"><bold>Problem-Solving and Coping Skills</bold></td>
</tr>
<tr>
<td> Amoako and Skelly 2007<sup><xref ref-type="bibr" rid="bibr50-0145721712464400">50</xref></sup>; Amoako et al 2008<sup><xref ref-type="bibr" rid="bibr51-0145721712464400">51</xref></sup></td>
<td>Evaluate a 4-week problem-solving and cognitive reframing telephone intervention in older African American women with diabetes.</td>
<td>Randomized, controlled trial; older African American assigned to the intervention or usual care.</td>
<td>N = 68</td>
<td>The intervention increased participation in exercise, psychosocial adjustment, problem solving, and uncertainty compared with usual care.</td>
</tr>
<tr>
<td> Gregg et al 2007<sup><xref ref-type="bibr" rid="bibr52-0145721712464400">52</xref></sup></td>
<td>Compare ACT, a coping skills intervention plus diabetes education to diabetes education alone.</td>
<td>Randomized, controlled trial; adults with type 2 diabetes assigned to ACT plus education or education alone.</td>
<td>N = 81</td>
<td>After 3 months, the ACT group showed increased use of acceptance and mindfulness coping strategies and improved diabetes self-care. Changes in acceptance coping and self-care mediated the effect of ACT on glycemic control.</td>
</tr>
<tr>
<td colspan="5"><bold>CBT and Behavior Therapy</bold></td>
</tr>
<tr>
<td> Van Bastelaar et al 2011<sup><xref ref-type="bibr" rid="bibr53-0145721712464400">53</xref></sup></td>
<td>Evaluate a Web-based CBT intervention for adults with type 1 or type 2 diabetes.</td>
<td>Randomized controlled trial; adult patients with elevated depressive symptoms assigned to Web-based intervention or wait-list control.</td>
<td>N = 255</td>
<td>The Web-based CBT intervention group experienced greater reductions in depressive symptoms and diabetes-specific emotional distress.</td>
</tr>
<tr>
<td> Ismail et al 2010<sup><xref ref-type="bibr" rid="bibr90-0145721712464400">90</xref></sup></td>
<td>Compare effects of MET plus CBT to MET alone and usual care.</td>
<td>Three-arm parallel randomized controlled trial of adults with inadequately controlled diabetes.</td>
<td>N = 344</td>
<td>There was no significant effect of either MET plus CBT or MET alone compared with usual care on depression or QOL.</td>
</tr>
<tr>
<td> Lehmkuhl et al 2010<sup><xref ref-type="bibr" rid="bibr56-0145721712464400">56</xref></sup></td>
<td>Evaluate a TBT for youths with type 1 diabetes and a parent/caregiver.</td>
<td>Randomized controlled trial; child–parent dyads randomized to 12-week TBT or wait-list control.</td>
<td>N = 32</td>
<td>Youth perception of unsupportive behaviors increased and perception of caring parental behaviors decreased in the TBT vs control group.</td>
</tr>
<tr>
<td> Amsberg et al 2009<sup><xref ref-type="bibr" rid="bibr59-0145721712464400">59</xref></sup></td>
<td>Evaluate CBT intervention delivered in a combined group/individual format.</td>
<td>Randomized controlled trial; adults with poorly controlled type 1 diabetes assigned to intervention or control group.</td>
<td>N = 94</td>
<td>The CBT group experienced greater improvements in well-being, diabetes-related distress, perceived stress, anxiety, and depression.</td>
</tr>
<tr>
<td> Snoek et al 2008<sup><xref ref-type="bibr" rid="bibr57-0145721712464400">57</xref></sup></td>
<td>Compare CBT delivered in a group format to BGAT in adults with poorly controlled type 1 diabetes, and examine whether effects varied by baseline depression.</td>
<td>Randomized trial; adults assigned to CBT or BGAT.</td>
<td>N = 86</td>
<td>Both CBT and BGAT improved depressive symptoms at 12-month follow-up.</td>
</tr>
<tr>
<td> Salamon et al 2010<sup><xref ref-type="bibr" rid="bibr54-0145721712464400">54</xref></sup></td>
<td>Evaluate a 1-hour CBT-based intervention with 3 weekly follow-up phone calls in adolescents with type 1 diabetes; intervention focused on cognitive restructuring and problem-solving training.</td>
<td>Pre–post within-group evaluation; adolescents with poorly controlled diabetes.</td>
<td>N = 10</td>
<td>Pre–post differences in diabetes-related stress and concerns about self-care in social situations were not significant, but there was a trend toward improvement in concerns about self-care in social situations.</td>
</tr>
<tr>
<td> Monaghan et al 2011<sup><xref ref-type="bibr" rid="bibr55-0145721712464400">55</xref></sup></td>
<td>Evaluate feasibility and initial efficacy of a telephone intervention based on social cognitive theory and incorporating cognitive–behavioral techniques for parents of young children with type 1 diabetes.</td>
<td>Randomized trial (treatment vs wait-list control group); initial analyses were for pre–post changes in the 14 parents assigned to the initial treatment group.</td>
<td>N = 14</td>
<td>Parenting stress and perceived social support improved for parents after participating in the intervention.</td>
</tr>
<tr>
<td colspan="5"><bold>Family Therapy</bold></td>
</tr>
<tr>
<td> Harris et al 2009<sup><xref ref-type="bibr" rid="bibr61-0145721712464400">61</xref></sup></td>
<td>Evaluate a 10-session, home-based BFST for adolescents with poorly controlled type 1 diabetes.</td>
<td>Pre–post evaluation with normative outcome comparison using data from adolescents with poor diabetes control included in a previous study.</td>
<td>N = 58</td>
<td>The BFST intervention decreased diabetes-related family conflict by 1/3 to 1/2 of a standard deviation, and general family conflict decreased from 1/3 to 1/2 of a standard deviation.</td>
</tr>
<tr>
<td> Nansel et al 2009<sup><xref ref-type="bibr" rid="bibr91-0145721712464400">91</xref></sup></td>
<td>Evaluate the feasibility of a family problem-solving behavioral intervention (WE*CAN) delivered by nonmedical “health advisors.”</td>
<td>Randomized, controlled trial; families of children with type 1 diabetes were randomized to the family problem-solving intervention or usual care.</td>
<td>N = 122</td>
<td>The intervention demonstrated good feasibility. No significant changes were observed in QOL, parent–child conflict, or family responsibility sharing, but study was not powered for outcome analysis.</td>
</tr>
<tr>
<td> Ellis et al 2007<sup><xref ref-type="bibr" rid="bibr92-0145721712464400">92</xref></sup>; 2007<sup><xref ref-type="bibr" rid="bibr94-0145721712464400">94</xref></sup>; 2007<sup><xref ref-type="bibr" rid="bibr95-0145721712464400">95</xref></sup>; 2008<sup><xref ref-type="bibr" rid="bibr93-0145721712464400">93</xref></sup></td>
<td>Evaluate MST for adolescents with poorly controlled type 1 diabetes, and examine family composition (2- vs 1-parent families) as a moderator of treatment effects.</td>
<td>Randomized, controlled trial; adolescents assigned to MST or control.</td>
<td>N = 127</td>
<td>There was evidence for improved family relationships in 2-parent families but not single-parent families.</td>
</tr>
<tr>
<td> Wysocki et al 2007<sup><xref ref-type="bibr" rid="bibr96-0145721712464400">96</xref></sup>; 2006<sup><xref ref-type="bibr" rid="bibr62-0145721712464400">62</xref></sup>; 2008<sup><xref ref-type="bibr" rid="bibr63-0145721712464400">63</xref></sup></td>
<td>Compare BFST intervention to an ES group in families of adolescents with diabetes.</td>
<td>Randomized, controlled trial; families assigned to BFST, ES, or usual care.</td>
<td>N = 104</td>
<td>At treatment end, those receiving BFST had improved family conflict and adherence compared with those receiving ES or usual care, with greater effects in adolescents with very poor initial metabolic control. BFST also resulted in greater improvements in family interaction and problem solving relative to both ES and usual care.</td>
</tr>
<tr>
<td colspan="5"><bold>Medications</bold></td>
</tr>
<tr>
<td> Echeverry et al 2009<sup><xref ref-type="bibr" rid="bibr64-0145721712464400">64</xref></sup></td>
<td>Compare sertraline vs placebo for treatment of depression in low-income Hispanic and African American patients with diabetes.</td>
<td>6-month randomized, double-blind, placebo-controlled trial.</td>
<td>N = 87</td>
<td>Depressive symptoms, QOL, and pain all improved in both the sertraline and placebo groups, with no significant differences between groups.</td>
</tr>
<tr>
<td> Williams et al 2007<sup><xref ref-type="bibr" rid="bibr65-0145721712464400">65</xref></sup></td>
<td>Examine effect of sertraline maintenance therapy on time-to-recurrence of major depressive disorder in younger vs older adults with diabetes.</td>
<td>52-week follow-up of patients achieving depression recovery after participating in a randomized, double-blind, placebo-controlled trial.</td>
<td>N = 152</td>
<td>In younger patients, sertraline yielded significantly greater protection against depression recurrence than placebo, but there was no difference in recurrence for older patients treated with sertraline vs placebo.</td>
</tr>
<tr>
<td colspan="5"><bold>Other Interventions</bold></td>
</tr>
<tr>
<td> Beever et al 2010<sup><xref ref-type="bibr" rid="bibr70-0145721712464400">70</xref></sup></td>
<td>Evaluate effect of 3-times weekly, 20-minute far-infrared sauna treatments on QOL in adults with type 2 diabetes.</td>
<td>Pre–post within-group comparison.</td>
<td/>
<td>Physical health, general health, social functioning, stress, and fatigue improved from pre-intervention to post-intervention.</td>
</tr>
<tr>
<td> Skoro-Kondza et al 2009<sup><xref ref-type="bibr" rid="bibr71-0145721712464400">71</xref></sup></td>
<td>Evaluate community-based yoga classes for adults with type 2 diabetes.</td>
<td>Randomized trial; adults with type 2 diabetes (not on insulin) were randomized to participate in twice-weekly, 90-minute yoga classes for 12 weeks or wait-list control group.</td>
<td>N = 59</td>
<td>The rate of ineligible patients was high, largely due to insulin treatment or contraindications to yoga (eg, ischemic heart disease, cerebrovascular disease), as was the rate of refusal due to lack of interest. The attendance rate at class was 50%. Intent-to-treat analyses showed no significant effects on QOL or self-efficacy.</td>
</tr>
<tr>
<td> Simson et al 2008<sup><xref ref-type="bibr" rid="bibr67-0145721712464400">67</xref></sup></td>
<td>Evaluate a supportive psychotherapy intervention with adult diabetic patients with lower extremity ulcers and comorbid depression.</td>
<td>Randomized, controlled trial; adult inpatients with diabetes, lower extremity ulcers, and comorbid depression were assigned to supportive psychotherapy or standard medical care.</td>
<td>N = 30</td>
<td>Symptoms of anxiety and depression and diabetes-related distress decreased in the intervention group but not the control group.</td>
</tr>
<tr>
<td> Menard et al 2007<sup><xref ref-type="bibr" rid="bibr68-0145721712464400">68</xref></sup></td>
<td>Evaluate effect of intensive multitherapy, consisting of monthly visits including individual and group DSME/T, intensive self-care regimens for SMBG, diet, and exercise; 2 intervisit phone calls for therapy adjustments, motivational support, and feedback; and initiation/intensification of medication/insulin therapy if needed.</td>
<td>Randomized, controlled trial; French adult patients with poorly controlled type 2 diabetes and comorbid hypertension and dyslipidemia assigned to intervention or standard medical care.</td>
<td>N = 72</td>
<td>QOL was improved in the intervention group relative to control, along with knowledge and self-management behavior. No significant changes in attitudes about diabetes.</td>
</tr>
<tr>
<td> Benhamou et al 2007<sup><xref ref-type="bibr" rid="bibr69-0145721712464400">69</xref></sup></td>
<td>Evaluate a Web-based telemedicine intervention using cellular phones and short message service (ie texting) compared with usual care in adults with type 1 diabetes</td>
<td>Bicenter, open-label, randomized, 2-period, crossover 12-month study; adults with type 1 diabetes on pump therapy assigned to intervention or wait-list control.</td>
<td>N = 30</td>
<td>QOL improved significantly more in the intervention group, and 76% of patients felt that the quality of their medical care was higher during the intervention period.</td>
</tr>
<tr>
<td colspan="5"><bold>Approaches in Primary Care</bold></td>
</tr>
<tr>
<td> Ell et al 2010<sup><xref ref-type="bibr" rid="bibr74-0145721712464400">74</xref></sup></td>
<td>Compare effectiveness of collaborative depression care vs usual primary care in older vs younger adults with chronic physical illnesses, including diabetes, cancer, and others.</td>
<td>Pooled, intent-to-treat analyses of 3 randomized controlled trials of collaborative depression care consisting of choice of first-line depression therapy (psychotherapy, medication, or both) and a structured algorithm for stepped care.</td>
<td>N = 1081</td>
<td>Both younger and older patients experienced a significant improvement in depressive symptoms and major depression rates at 6-month follow-up, with no difference in effectiveness by age group.</td>
</tr>
<tr>
<td> Katon et al 2008<sup><xref ref-type="bibr" rid="bibr72-0145721712464400">72</xref></sup></td>
<td>Evaluate the 5-year effects of the Pathways depression collaborative care intervention vs usual primary care on total health care costs.</td>
<td>Randomized controlled trial at 9 HMO primary care practices; adults with diabetes and depression assigned to nurse depression intervention consisting of education about depression, behavioral activation, and choice of starting with antidepressant medication or problem-solving therapy in primary care + stepped care as needed.</td>
<td>N = 329</td>
<td>There was a trend for reduced 5-year mean total medical costs in intervention patients (along with improved depression outcomes). The greatest cost reductions were seen in patients with most severe physical comorbidity.</td>
</tr>
<tr>
<td> Simon et al 2007<sup><xref ref-type="bibr" rid="bibr73-0145721712464400">73</xref></sup></td>
<td>Evaluate cost and cost-effectiveness of the Pathways depression collaborative care intervention vs usual primary care.</td>
<td>Randomized controlled trial at 9 HMO primary care practices; adults with diabetes and depression assigned to nurse depression intervention consisting of education about depression, behavioral activation, and choice of starting with antidepressant medication or problem-solving therapy in primary care + stepped care as needed.</td>
<td>N = 329</td>
<td>The Pathways intervention increased days free from depression and led to savings in outpatient health services costs. Both contributed to an estimated $952 saved per patient treated with the Pathways intervention.</td>
</tr>
<tr>
<td> Ell et al 2010<sup><xref ref-type="bibr" rid="bibr75-0145721712464400">75</xref></sup></td>
<td>Evaluate effectiveness of a socioculturally adapted collaborative care intervention in 387 low-income, predominantly Hispanic adults with diabetes and depression at 2 public safety-net clinics.</td>
<td>Randomized, controlled trial; low-income, primary Hispanic adults with diabetes and depression assigned to collaborative care (initial choice of problem-solving therapy or medication or both, plus stepped care as needed) or enhanced usual care (primary care plus educational pamphlets and community resource list).</td>
<td>N = 387</td>
<td>Participants receiving collaborative care experienced greater improvements in depressive symptoms; diabetes symptoms; anxiety; emotional, physical, and pain-related functioning; disability; and social stressors.</td>
</tr>
<tr>
<td> D.E. Knight et al 2008<sup><xref ref-type="bibr" rid="bibr77-0145721712464400">77</xref></sup></td>
<td>Evaluate feasibility of screening for depression and usefulness of this screening for identifying undiagnosed and undertreated depression using a student pharmacist at a pharmacist-managed diabetes care clinic for underserved, low-income, inner-city adult diabetic patients.</td>
<td>Cross-sectional study; patients attending a diabetes care clinic were screened for depression by a student pharmacist, who then abstracted additional information from their chart.</td>
<td>N = 45</td>
<td>The student pharmacist’s screening suggested that 75% of patients with previously diagnosed depression were being inadequately treated and 48% of patients with no prior depression diagnosis had significant depressive symptoms.</td>
</tr>
<tr>
<td> Goss et al 2010<sup><xref ref-type="bibr" rid="bibr76-0145721712464400">76</xref></sup></td>
<td>Evaluate a new, interdisciplinary model of rural pediatric diabetes care called RADICAL, which involved a co-located team of pediatrician, diabetes educator, and mental health nurse who regularly met to discuss each patient’s care, provided proactive child and family emotional support, and actively attempted to match insulin regimens with the patient’s lifestyle.</td>
<td>Pre–post evaluation of children under 21 years old with type 1 diabetes.</td>
<td>N = 61</td>
<td>The RADICAL model resulted in increased patient satisfaction and elimination of a previously documented rural–urban disparity in patient QOL.</td>
</tr>
<tr>
<td> Jones et al 2006<sup><xref ref-type="bibr" rid="bibr97-0145721712464400">97</xref></sup></td>
<td>Compare receipt of adequate antidepressant dosing and duration of therapy in veterans with vs without diabetes.</td>
<td>Retrospective cohort study of patients of a midwestern Veterans Affairs facility, including those with comorbid diabetes.</td>
<td>N = 2332</td>
<td>In depressed veterans, dosing of antidepressants was adequate but treatment duration often fell short. A diabetes diagnosis did not adversely affect antidepressant treatment quality.</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn2-0145721712464400"><p>Abbreviations: ACT, acceptance and commitment therapy; BFST, behavioral family systems therapy; BGAT, blood-glucose awareness training; CBT, cognitive–behavioral therapy; DAFNE, Dose Adjustment for Normal Eating; DID, diabetes interactive diary; DSME/T, diabetes self-management education/therapy; ES, educational support; HMO, health maintenance organization; MET, motivational enhancement therapy; MST, multisystemic therapy; NCM, nurse case management; QOL, quality of life; RPS, reciprocal peer-support; SMBG, self-monitoring of blood glucose; TBT, telehealth behavioral therapy.</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
</sec>
<sec id="section11-0145721712464400" sec-type="results">
<title>Results</title>
<sec id="section12-0145721712464400">
<title>Part 1: Impact of Diabetes Treatments on Quality of Life</title>
<p>A total of 45 original research studies and 14 review articles were identified that examined psychosocial and QOL outcomes of different diabetes treatment approaches. One of the most active areas of research suggests mostly, but not entirely,<sup><xref ref-type="bibr" rid="bibr3-0145721712464400">3</xref></sup> positive effects of continuous subcutaneous insulin injection (CSII; ie, insulin pump therapy) relative to multiple daily injections (MDIs) on treatment satisfaction, emotional health, and QOL in youth with T1DM,<sup><xref ref-type="bibr" rid="bibr4-0145721712464400">4</xref><xref ref-type="bibr" rid="bibr5-0145721712464400"/><xref ref-type="bibr" rid="bibr6-0145721712464400"/><xref ref-type="bibr" rid="bibr7-0145721712464400"/><xref ref-type="bibr" rid="bibr8-0145721712464400"/>-<xref ref-type="bibr" rid="bibr9-0145721712464400">9</xref></sup> their parents,<sup><xref ref-type="bibr" rid="bibr5-0145721712464400">5</xref>,<xref ref-type="bibr" rid="bibr10-0145721712464400">10</xref><xref ref-type="bibr" rid="bibr11-0145721712464400"/>-<xref ref-type="bibr" rid="bibr12-0145721712464400">12</xref></sup> and adults with T1DM.<sup><xref ref-type="bibr" rid="bibr13-0145721712464400">13</xref>,<xref ref-type="bibr" rid="bibr14-0145721712464400">14</xref></sup> Although only the Opipari-Arrigan<sup><xref ref-type="bibr" rid="bibr11-0145721712464400">11</xref></sup> study involving preschoolers with T1DM and their parents used a randomized controlled design, the remaining observational studies have the advantage of increased generalizability to real-world shared decision making about treatments (ie, for patients who elect to use the pump, coping and QOL tend to improve). Insulin pump use in T2DM has been studied much less frequently. One study<sup><xref ref-type="bibr" rid="bibr15-0145721712464400">15</xref></sup> showed improved QOL and treatment satisfaction in patients switching from injections to CSII but no effect in patients previously taking oral hypoglycemic agents (OHAs) only; another study<sup><xref ref-type="bibr" rid="bibr16-0145721712464400">16</xref></sup> reported no overall QOL differences for CSII versus MDI. Other treatment advances such as inhaled insulin,<sup><xref ref-type="bibr" rid="bibr17-0145721712464400">17</xref>,<xref ref-type="bibr" rid="bibr18-0145721712464400">18</xref></sup> continuous glucose monitoring,<sup><xref ref-type="bibr" rid="bibr19-0145721712464400">19</xref><xref ref-type="bibr" rid="bibr20-0145721712464400"/>-<xref ref-type="bibr" rid="bibr21-0145721712464400">21</xref></sup> continuous intraperitoneal insulin infusion,<sup><xref ref-type="bibr" rid="bibr22-0145721712464400">22</xref></sup> pancreatic-kidney<sup><xref ref-type="bibr" rid="bibr23-0145721712464400">23</xref></sup> and islet cell<sup><xref ref-type="bibr" rid="bibr24-0145721712464400">24</xref></sup> transplantation, and supplemental metformin therapy<sup><xref ref-type="bibr" rid="bibr25-0145721712464400">25</xref></sup> in T1DM have demonstrated positive QOL impacts, but small numbers of studies and observational designs prohibit any firm conclusions.</p>
<p>Another active area has been how to intensify treatment in T2DM in a way that maximizes QOL when initial lifestyle changes and OHAs fail to adequately control blood glucose. As evidenced by studies listed in <xref ref-type="table" rid="table1-0145721712464400">Table 1</xref><sup><xref ref-type="bibr" rid="bibr26-0145721712464400">26</xref><xref ref-type="bibr" rid="bibr27-0145721712464400"/><xref ref-type="bibr" rid="bibr28-0145721712464400"/><xref ref-type="bibr" rid="bibr29-0145721712464400"/><xref ref-type="bibr" rid="bibr30-0145721712464400"/><xref ref-type="bibr" rid="bibr31-0145721712464400"/><xref ref-type="bibr" rid="bibr32-0145721712464400"/>-<xref ref-type="bibr" rid="bibr33-0145721712464400">33</xref></sup>—all of which consisted of randomized controlled trials—treatment intensification in patients with poor glycemic control (eg, &gt;9.0%) typically improves both QOL and treatment satisfaction. In addition, there appears to be evidence of greater benefits when insulin or newer injectable agents (glucagon-like peptide [GLP] agonists and analogues, amylin analogues) are added to the patient’s medication regimen versus adding another OHA (eg, adding sitagliptin or pioglitazone to metformin only). This research, along with studies documenting high prevalence of side effects associated with OHAs,<sup><xref ref-type="bibr" rid="bibr34-0145721712464400">34</xref>,<xref ref-type="bibr" rid="bibr35-0145721712464400">35</xref></sup> suggests that insulin, and particularly insulin analogues,<sup><xref ref-type="bibr" rid="bibr36-0145721712464400">36</xref><xref ref-type="bibr" rid="bibr37-0145721712464400"/>-<xref ref-type="bibr" rid="bibr38-0145721712464400">38</xref></sup> or other injectable agents may be preferred over complex OHA regimens in T2DM patients.</p>
</sec>
<sec id="section13-0145721712464400">
<title>Part 2: Interventions to Promote Healthy Coping</title>
<p><xref ref-type="table" rid="table2-0145721712464400">Table 2</xref> summarizes key original research studies published in the past 5 years that evaluate interventions in terms of their effects on QOL and/or other psychosocial outcomes.</p>
<p>Several studies were identified that found diabetes self-management education (DSME) to improve QOL<sup><xref ref-type="bibr" rid="bibr39-0145721712464400">39</xref><xref ref-type="bibr" rid="bibr40-0145721712464400"/><xref ref-type="bibr" rid="bibr41-0145721712464400"/>-<xref ref-type="bibr" rid="bibr42-0145721712464400">42</xref></sup> and other psychosocial and emotional outcomes, such as depressive symptoms<sup><xref ref-type="bibr" rid="bibr43-0145721712464400">43</xref></sup> and treatment satisfaction,<sup><xref ref-type="bibr" rid="bibr42-0145721712464400">42</xref></sup> although in some cases, beneficial healthy coping effects were short-lived<sup><xref ref-type="bibr" rid="bibr44-0145721712464400">44</xref></sup> or not observed.<sup><xref ref-type="bibr" rid="bibr45-0145721712464400">45</xref>,<xref ref-type="bibr" rid="bibr46-0145721712464400">46</xref></sup> It is notable that of the 5 interventions in this category demonstrating positive effects, 4 focused on self-managing insulin in conjunction with diet for insulin-dependent and primarily T1DM patients.<sup><xref ref-type="bibr" rid="bibr39-0145721712464400">39</xref><xref ref-type="bibr" rid="bibr40-0145721712464400"/><xref ref-type="bibr" rid="bibr41-0145721712464400"/>-<xref ref-type="bibr" rid="bibr42-0145721712464400">42</xref></sup> The only intervention targeted at patients with T2DM that showed positive effects focused on self-monitoring of blood glucose and patient motivation but did not use a randomized, controlled design.<sup><xref ref-type="bibr" rid="bibr43-0145721712464400">43</xref></sup> This pattern of results suggests that QOL and other psychosocial outcomes in T2DM may require more intensive or coping-focused efforts beyond DSME.</p>
<p>Several studies suggested promising effects of adult patients’ participation in diabetes support groups in diverse settings, including 2 well-designed, randomized controlled trials.<sup><xref ref-type="bibr" rid="bibr47-0145721712464400">47</xref>,<xref ref-type="bibr" rid="bibr48-0145721712464400">48</xref></sup> In the first trial, improved QOL in 4 domains (physical health, psychological health, social participation, and environment) was observed among Thai patients participating in a 16-week self-help group.<sup><xref ref-type="bibr" rid="bibr47-0145721712464400">47</xref></sup> In the second trial, improved perceptions of social support and willingness to initiate insulin were observed among male veterans participating in a reciprocal peer support program with supplemental group sessions, although diabetes-related distress was not significantly different across groups.<sup><xref ref-type="bibr" rid="bibr48-0145721712464400">48</xref></sup> Finally, a small pilot study demonstrated improved activity and vigor levels in urban, minority adults participating in peer-led community discussion circles, although it did not elicit significant changes in other aspects of well-being.<sup><xref ref-type="bibr" rid="bibr49-0145721712464400">49</xref></sup> The diversity of the patient populations across these 3 studies suggests that the use of peer support may be a strategy that is potentially robust across patient subgroups, at least among adults. However, the few peer support studies identified overall, the lack of studies in youth with diabetes, and heterogeneity in the specific psychosocial outcomes assessed highlight the need for more research to understand the full potential of peer support in facilitating healthy coping.</p>
<p>Recent studies also provide evidence for the efficacy of problem-solving and coping skills interventions when delivered to adults with T2DM. One randomized controlled trial showed that a 4-week problem-solving and cognitive reframing, telephone-based intervention for older African American women improved psychosocial adjustment and problem solving, reduced uncertainty, and increased participation in physical activity.<sup><xref ref-type="bibr" rid="bibr50-0145721712464400">50</xref>,<xref ref-type="bibr" rid="bibr51-0145721712464400">51</xref></sup> Another intervention found that increasing one’s use of acceptance and mindfulness coping strategies improved diabetes self-care.<sup><xref ref-type="bibr" rid="bibr52-0145721712464400">52</xref></sup> These studies suggest that an emphasis on problem solving may benefit psychosocial outcomes in addition to self-care behavior and glycemic control, although more studies evaluating a common set of healthy coping outcomes are needed in this area as well.</p>
<p>There has been substantial interest in cognitive behavioral therapy (CBT), including several studies suggesting effectiveness of CBT-based interventions on depressive symptoms and diabetes-related stress, when delivered via novel formats, such as the Internet and/or telephone.<sup><xref ref-type="bibr" rid="bibr53-0145721712464400">53</xref><xref ref-type="bibr" rid="bibr54-0145721712464400"/>-<xref ref-type="bibr" rid="bibr55-0145721712464400">55</xref></sup> However, evidence from recent trials is mixed, with some suggestion of less favorable results when these interventions are delivered to youth and/or youth–parent dyads<sup><xref ref-type="bibr" rid="bibr54-0145721712464400">54</xref>,<xref ref-type="bibr" rid="bibr56-0145721712464400">56</xref></sup> compared with parents alone<sup><xref ref-type="bibr" rid="bibr55-0145721712464400">55</xref></sup> or adult patients.<sup><xref ref-type="bibr" rid="bibr53-0145721712464400">53</xref>,<xref ref-type="bibr" rid="bibr57-0145721712464400">57</xref><xref ref-type="bibr" rid="bibr58-0145721712464400"/>-<xref ref-type="bibr" rid="bibr59-0145721712464400">59</xref></sup> In addition, a recent randomized trial of group CBT suggests that CBT may be most helpful for patients who are experiencing higher versus lower levels of depressive symptoms.<sup><xref ref-type="bibr" rid="bibr57-0145721712464400">57</xref></sup> A recent review of interventions for individuals with diabetes and depression also noted the greatest improvements in depression for CBT compared with other psychotherapeutic or pharmacological approaches.<sup><xref ref-type="bibr" rid="bibr60-0145721712464400">60</xref></sup></p>
<p>Several studies of family therapy approaches applied to youth with T1DM and their families have produced good evidence of positive initial impacts on family conflict<sup><xref ref-type="bibr" rid="bibr61-0145721712464400">61</xref>,<xref ref-type="bibr" rid="bibr62-0145721712464400">62</xref></sup> and interaction,<sup><xref ref-type="bibr" rid="bibr63-0145721712464400">63</xref></sup> adherence,<sup><xref ref-type="bibr" rid="bibr62-0145721712464400">62</xref></sup> and problem solving.<sup><xref ref-type="bibr" rid="bibr63-0145721712464400">63</xref></sup> The methodological quality of these studies was high, with 3 of these 4 studies using randomized controlled designs comparing family therapy to usual care and/or education support. No family therapy interventions were identified for adults with either T1DM or T2DM, a major oversight in the literature.</p>
<p>Additional evidence for the efficacy of sertraline in reducing depressive symptoms among adult patients, as well as improving QOL and pain, was found in one randomized, double-blind, controlled trial that involved low-income minority patients with diabetes and comorbid depression.<sup><xref ref-type="bibr" rid="bibr64-0145721712464400">64</xref></sup> However, another trial<sup><xref ref-type="bibr" rid="bibr65-0145721712464400">65</xref></sup> of the ability of sertraline to prevent recurrence of major depressive disorder in diabetic patients achieving initial depression recovery found evidence of efficacy only in younger patients, suggesting that nonmedication approaches with older adults may be more appropriate. A notable gap in the literature is the absence of studies examining the use of antidepressant medication in conjunction with or in comparison with nonpharmaceutical, guideline- recommended<sup><xref ref-type="bibr" rid="bibr66-0145721712464400">66</xref></sup> depression therapies (eg, CBT, problem-solving therapy).</p>
<p>Other promising intervention approaches identified in the past 5 years via relatively small pilot studies include supportive psychotherapy for adults with comorbid depression,<sup><xref ref-type="bibr" rid="bibr67-0145721712464400">67</xref></sup> intensive multitherapy for improving QOL and self-care behavior,<sup><xref ref-type="bibr" rid="bibr68-0145721712464400">68</xref></sup> telemedicine support using short-messaging service (ie, texting) for improving QOL,<sup><xref ref-type="bibr" rid="bibr69-0145721712464400">69</xref></sup> and far-infrared sauna treatments for improving physical health, general health, social functioning, stress, and fatigue.<sup><xref ref-type="bibr" rid="bibr70-0145721712464400">70</xref></sup> Larger, randomized trials of these approaches are warranted. There has also been interest in the utility of yoga classes for improving QOL, but one randomized trial found difficulties in implementing such classes and no impact on QOL.<sup><xref ref-type="bibr" rid="bibr71-0145721712464400">71</xref></sup></p>
<p>There has been considerable interest in developing and evaluating approaches to support healthy coping in the delivery of primary care: for example, collaborative care interventions for comorbid depression in diabetic patients. Recent findings support the long-term maintenance of effects of collaborative care on depression<sup><xref ref-type="bibr" rid="bibr72-0145721712464400">72</xref>,<xref ref-type="bibr" rid="bibr73-0145721712464400">73</xref></sup> and its effectiveness when applied to both younger and older patients<sup><xref ref-type="bibr" rid="bibr74-0145721712464400">74</xref></sup> as well as public safety-net clinics serving primarily low-income, Hispanic adults with diabetes.<sup><xref ref-type="bibr" rid="bibr75-0145721712464400">75</xref></sup> Other research supports the utility of the RADICAL model for eliminating rural–urban disparities in QOL among pediatric diabetic patients, which implements a co-located team consisting of a pediatrician, diabetes educator, and mental health nurse who meet regularly to discuss each patient’s care and provide preference-matched therapy and emotional support to children and their families.<sup><xref ref-type="bibr" rid="bibr76-0145721712464400">76</xref></sup> Additional research has demonstrated the feasibility of employing pharmacy students in a pharmacist-managed diabetes clinic to improve the identification of comorbid depression in diabetic patients.<sup><xref ref-type="bibr" rid="bibr77-0145721712464400">77</xref></sup> Thus, innovative care models that integrate mental health care into traditional diabetes care settings appear to be a feasible and effective way of supporting healthy coping across different patient populations.</p>
</sec>
</sec>
<sec id="section14-0145721712464400" sec-type="discussion">
<title>Discussion, Conclusions, and Implications</title>
<p>Findings from studies published in the past 5 years, and particularly the recent proliferation of articles examining psychosocial impacts of different diabetes treatments, suggest growing appreciation within the medical and research communities of the complex relationships between diabetes treatment, psychosocial factors, and metabolic control and the importance of explicitly considering QOL effects when treating diabetic patients. The findings are also encouraging in that they suggest that there is much that diabetes educators and other health care providers can do to improve coping, emotional health, and QOL in their patients:</p>
<list id="list1-0145721712464400" list-type="bullet"><list-item><p>Treatment intensification in response to poor metabolic control often improves both clinical and QOL outcomes.</p></list-item>
<list-item><p>Type of diabetes treatment may have a large impact on QOL and other psychosocial outcomes, suggesting that regimen changes in light of high levels of distress and/or low health-related QOL should be considered and discussed with patients. A wide range of instruments are available for assessing psychosocial and QOL effects of diabetes and its treatment, as described previously.<sup><xref ref-type="bibr" rid="bibr1-0145721712464400">1</xref></sup></p></list-item>
<list-item><p>Use of CSII in T1DM and other intensive therapies in diabetes generally, as well as earlier initiation of insulin and/or minimizing complexity of OHA regimens in T2DM diabetes specifically, can elicit improved emotional health and QOL.</p></list-item>
<list-item><p>A variety of intervention approaches for enhancing healthy coping continue to show positive results, providing educators and program planners an opportunity to choose and implement options based on the needs and preferences of their patients and available resources.</p></list-item>
<list-item><p>With regard to the treatment of comorbid depression, CBT and collaborative care interventions have elicited some of the strongest supportive evidence for effectiveness in real-world settings.</p></list-item></list>
<p>From these conclusions, a broad pattern emerges of considerable importance. It seems now well established that for a range of tactics and approaches to enhancing quality of diabetes care, better control of diabetes leads to better QOL. Given the frequency of multiple comorbidities in diabetes, clinicians may be hesitant to complicate regimens in a manner that places too great a burden on patients. Also, it has long been recognized that adherence is compromised by complexity of treatment regimens.<sup><xref ref-type="bibr" rid="bibr78-0145721712464400">78</xref></sup> Nevertheless, it appears that enhancing the intensity of treatment when glycemic control is poor is typically associated not so much with greater experienced burden and distress but with feeling better.</p>
</sec>
<sec id="section15-0145721712464400">
<title>Research Gaps</title>
<p>As the number and heterogeneity of medical treatments for controlling blood glucose in diabetes continue to expand, there remains an ongoing need for research comparing the effect of these different options on healthy coping outcomes. This research should examine the possibility that psychosocial and QOL effects of different treatments may vary across subpopulations, reflecting the different needs and unique circumstances of these groups. For example, the effects of treatment intensification on QOL among older, frail adults with multiple comorbidities may be very different than among those in their 40s or 50s whose principal medical problem is diabetes. Thus, there is a need for additional research comparing the effect of different diabetes treatment regimens on healthy coping outcomes in the growing population of older, frail diabetic patients with multiple comorbidities. This is of critical importance given that in older, frail patients, medication-related problems, adverse events, and risk of hypoglycemia are much more common and that minimizing treatment burden for patients and caregivers is of greater concern compared with intense glycemic control.<sup><xref ref-type="bibr" rid="bibr79-0145721712464400">79</xref><xref ref-type="bibr" rid="bibr80-0145721712464400"/>-<xref ref-type="bibr" rid="bibr81-0145721712464400">81</xref></sup></p>
<p>As noted above, there is at least preliminary evidence supporting the efficacy and/or effectiveness of a number of diverse intervention approaches to directly targeting coping outcomes in diabetic patients. The downside of these multiple options is that diabetes educators may be uncertain as to which options may produce the best outcomes in their patient populations. There is a need to conduct head-to-head comparisons of different approaches identified in this review for directly targeting coping outcomes in diabetes with varying amounts of evidence for efficacy and effectiveness. In addition, some approaches have very good evidence in specific subpopulations (eg, family therapy for youth with T1DM) but have been virtually untested in other populations where they may be similar useful (eg, older patients with reduced functional independence). Future research should examine the feasibility and effectiveness of adapting such approaches for use with a broader range of patient populations.</p>
<p>Finally, there is a continued need for greater dissemination of approaches identified as efficacious or effective in a particular setting.<sup><xref ref-type="bibr" rid="bibr1-0145721712464400">1</xref></sup> The greatest challenge remains how to practically translate interventions into routine care so that more patients can benefit. More research into large-scale dissemination methods as well as intervention toolkits and guides is sorely needed. Among existing resources is Healthy Coping in Diabetes: A Guide for Program Development and Implementation.<sup><xref ref-type="bibr" rid="bibr82-0145721712464400">82</xref></sup> This guide and other materials developed by the Robert Wood Johnson Foundation Diabetes Initiative (<ext-link ext-link-type="uri" xlink:href="http://diabetesnpo.im.wustl.edu/">http://diabetesnpo.im.wustl.edu/</ext-link>), as well as professional and patient-education materials of the AADE and American Diabetes Association, may be especially helpful for those in the field.</p>
</sec>
</body>
<back>
<ack>
<p>Support was provided by the Health Innovation Program and the Community-Academic Partnerships core of the University of Wisconsin Institute for Clinical and Translational Research (UW ICTR), grant 1UL1RR025011 from the Clinical and Translational Science Award (CTSA) program of the National Center for Research Resources, the National Institutes of Health, and the Peers for Progress of the American Academy of Family Physicians Foundation (Dr Fisher). Additional funding for this project was provided by the UW School of Medicine and Public Health from the Wisconsin Partnership Program and the Centennial Scholars Program. The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs, the United States government, the University of Pittsburgh, the University of Wisconsin, or the University of North Carolina.</p>
</ack>
<fn-group>
<fn fn-type="supplementary-material">
<p>Supplemental material for this article is available on <italic>The Diabetes Educator</italic> Web site at <ext-link ext-link-type="uri" xlink:href="http://tde.sagepub.com/supplemental">http://tde.sagepub.com/supplemental</ext-link>.</p></fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0145721712464400">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fisher</surname><given-names>EB</given-names></name>
<name><surname>Thorpe</surname><given-names>CT</given-names></name>
<name><surname>Devellis</surname><given-names>BM</given-names></name>
<name><surname>Devellis</surname><given-names>RF</given-names></name>
</person-group>. <article-title>Healthy coping, negative emotions, and diabetes management: a systematic review and appraisal</article-title>. <source>Diabetes Educ</source>. <year>2007</year>;<volume>33</volume>(<issue>6</issue>):<fpage>1080</fpage>-<lpage>1103</lpage>; discussion 1104-1086.</citation>
</ref>
<ref id="bibr2-0145721712464400">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Siminoff</surname><given-names>LA</given-names></name>
<name><surname>Gordon</surname><given-names>NH</given-names></name>
<name><surname>Silverman</surname><given-names>P</given-names></name>
<name><surname>Budd</surname><given-names>T</given-names></name>
<name><surname>Ravdin</surname><given-names>PM</given-names></name>
</person-group>. <article-title>A decision aid to assist in adjuvant therapy choices for breast cancer</article-title>. <source>Psychooncology</source>. <year>2006</year>;<volume>15</volume>(<issue>11</issue>):<fpage>1001</fpage>-<lpage>1013</lpage>.</citation>
</ref>
<ref id="bibr3-0145721712464400">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wu</surname><given-names>YP</given-names></name>
<name><surname>Graves</surname><given-names>MM</given-names></name>
<name><surname>Roberts</surname><given-names>MC</given-names></name>
<name><surname>Mitchell</surname><given-names>AC</given-names></name>
</person-group>. <article-title>Is insulin pump therapy better than injection for adolescents with diabetes?</article-title> <source>Diabetes Res Clin Pract</source>. <year>2010</year>;<volume>89</volume>(<issue>2</issue>):<fpage>121</fpage>-<lpage>125</lpage>.</citation>
</ref>
<ref id="bibr4-0145721712464400">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cortina</surname><given-names>S</given-names></name>
<name><surname>Repaske</surname><given-names>DR</given-names></name>
<name><surname>Hood</surname><given-names>KK</given-names></name>
</person-group>. <article-title>Sociodemographic and psychosocial factors associated with continuous subcutaneous insulin infusion in adolescents with type 1 diabetes</article-title>. <source>Pediatr Diabetes</source>. <year>2010</year>;<volume>11</volume>(<issue>5</issue>):<fpage>337</fpage>-<lpage>344</lpage>.</citation>
</ref>
<ref id="bibr5-0145721712464400">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Muller-Godeffroy</surname><given-names>E</given-names></name>
<name><surname>Treichel</surname><given-names>S</given-names></name>
<name><surname>Wagner</surname><given-names>VM</given-names></name>
</person-group>. <article-title>Investigation of quality of life and family burden issues during insulin pump therapy in children with type 1 diabetes mellitus—a large-scale multicentre pilot study</article-title>. <source>Diabet Med</source>. <year>2009</year>;<volume>26</volume>(<issue>5</issue>):<fpage>493</fpage>-<lpage>501</lpage>.</citation>
</ref>
<ref id="bibr6-0145721712464400">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Juliusson</surname><given-names>PB</given-names></name>
<name><surname>Graue</surname><given-names>M</given-names></name>
<name><surname>Wentzel-Larsen</surname><given-names>T</given-names></name>
<name><surname>Sovik</surname><given-names>O</given-names></name>
</person-group>. <article-title>The impact of continuous subcutaneous insulin infusion on health-related quality of life in children and adolescents with type 1 diabetes</article-title>. <source>Acta Paediatr</source>. <year>2006</year>;<volume>95</volume>(<issue>11</issue>):<fpage>1481</fpage>-<lpage>1487</lpage>.</citation>
</ref>
<ref id="bibr7-0145721712464400">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hofer</surname><given-names>SE</given-names></name>
<name><surname>Heidtmann</surname><given-names>B</given-names></name>
<name><surname>Raile</surname><given-names>K</given-names></name>
<etal/></person-group>. <article-title>Discontinuation of insulin pump treatment in children, adolescents, and young adults: a multicenter analysis based on the DPV database in Germany and Austria</article-title>. <source>Pediatr Diabetes</source>. <year>2010</year>;<volume>11</volume>(<issue>2</issue>):<fpage>116</fpage>-<lpage>121</lpage>.</citation>
</ref>
<ref id="bibr8-0145721712464400">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cogen</surname><given-names>FR</given-names></name>
<name><surname>Henderson</surname><given-names>C</given-names></name>
<name><surname>Hansen</surname><given-names>JA</given-names></name>
<name><surname>Streisand</surname><given-names>R</given-names></name>
</person-group>. <article-title>Pediatric quality of life in transitioning to the insulin pump: does prior regimen make a difference?</article-title> <source>Clin Pediatr (Phila)</source>. <year>2007</year>;<volume>46</volume>(<issue>9</issue>):<fpage>777</fpage>-<lpage>779</lpage>.</citation>
</ref>
<ref id="bibr9-0145721712464400">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Knight</surname><given-names>S</given-names></name>
<name><surname>Northam</surname><given-names>E</given-names></name>
<name><surname>Donath</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Improvements in cognition, mood and behaviour following commencement of continuous subcutaneous insulin infusion therapy in children with type 1 diabetes mellitus: a pilot study</article-title>. <source>Diabetologia</source>. <year>2009</year>;<volume>52</volume>(<issue>2</issue>):<fpage>193</fpage>-<lpage>198</lpage>.</citation>
</ref>
<ref id="bibr10-0145721712464400">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wilson</surname><given-names>V</given-names></name>
</person-group>. <article-title>Experiences of parents of young people with diabetes using insulin pump therapy</article-title>. <source>Paediatr Nurs</source>. <year>2008</year>;<volume>20</volume>(<issue>2</issue>):<fpage>14</fpage>-<lpage>18</lpage>.</citation>
</ref>
<ref id="bibr11-0145721712464400">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Opipari-Arrigan</surname><given-names>L</given-names></name>
<name><surname>Fredericks</surname><given-names>EM</given-names></name>
<name><surname>Burkhart</surname><given-names>N</given-names></name>
<name><surname>Dale</surname><given-names>L</given-names></name>
<name><surname>Hodge</surname><given-names>M</given-names></name>
<name><surname>Foster</surname><given-names>C</given-names></name>
</person-group>. <article-title>Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus</article-title>. <source>Pediatr Diabetes</source>. <year>2007</year>;<volume>8</volume>(<issue>6</issue>):<fpage>377</fpage>-<lpage>383</lpage>.</citation>
</ref>
<ref id="bibr12-0145721712464400">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ingerski</surname><given-names>LM</given-names></name>
<name><surname>Laffel</surname><given-names>L</given-names></name>
<name><surname>Drotar</surname><given-names>D</given-names></name>
<name><surname>Repaske</surname><given-names>D</given-names></name>
<name><surname>Hood</surname><given-names>KK</given-names></name>
</person-group>. <article-title>Correlates of glycemic control and quality of life outcomes in adolescents with type 1 diabetes</article-title>. <source>Pediatr Diabetes</source>. <year>2010</year>;<volume>11</volume>(<issue>8</issue>):<fpage>563</fpage>-<lpage>571</lpage>.</citation>
</ref>
<ref id="bibr13-0145721712464400">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Scheidegger</surname><given-names>U</given-names></name>
<name><surname>Allemann</surname><given-names>S</given-names></name>
<name><surname>Scheidegger</surname><given-names>K</given-names></name>
<name><surname>Diem</surname><given-names>P</given-names></name>
</person-group>. <article-title>Continuous subcutaneous insulin infusion therapy: effects on quality of life</article-title>. <source>Swiss Med Wkly</source>. <year>2007</year>;<volume>137</volume>(<issue>33-34</issue>):<fpage>476</fpage>-<lpage>482</lpage>.</citation>
</ref>
<ref id="bibr14-0145721712464400">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Todres</surname><given-names>L</given-names></name>
<name><surname>Keen</surname><given-names>S</given-names></name>
<name><surname>Kerr</surname><given-names>D</given-names></name>
</person-group>. <article-title>Continuous subcutaneous insulin infusion in type 1 diabetes: patient experiences of “living with a machine.”</article-title> <source>Diabet Med</source>. <year>2010</year>;<volume>27</volume>(<issue>10</issue>):<fpage>1201</fpage>-<lpage>1204</lpage>.</citation>
</ref>
<ref id="bibr15-0145721712464400">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rubin</surname><given-names>RR</given-names></name>
<name><surname>Peyrot</surname><given-names>M</given-names></name>
<name><surname>Chen</surname><given-names>X</given-names></name>
<name><surname>Frias</surname><given-names>JP</given-names></name>
</person-group>. <article-title>Patient-reported outcomes from a 16-week open-label, multicenter study of insulin pump therapy in patients with type 2 diabetes mellitus</article-title>. <source>Diabetes Technol Ther</source>. <year>2010</year>;<volume>12</volume>(<issue>11</issue>):<fpage>901</fpage>-<lpage>906</lpage>.</citation>
</ref>
<ref id="bibr16-0145721712464400">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gurkova</surname><given-names>E</given-names></name>
<name><surname>Cap</surname><given-names>J</given-names></name>
<name><surname>Ziakova</surname><given-names>K</given-names></name>
</person-group>. <article-title>Quality of life and treatment satisfaction in the context of diabetes self-management education</article-title>. <source>Int J Nurs Pract</source>. <year>2009</year>;<volume>15</volume>(<issue>2</issue>):<fpage>91</fpage>-<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr17-0145721712464400">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Testa</surname><given-names>MA</given-names></name>
<name><surname>Simonson</surname><given-names>DC</given-names></name>
</person-group>. <article-title>Satisfaction and quality of life with premeal inhaled versus injected insulin in adolescents and adults with type 1 diabetes</article-title>. <source>Diabetes Care</source>. <year>2007</year>;<volume>30</volume>(<issue>6</issue>):<fpage>1399</fpage>-<lpage>1405</lpage>.</citation>
</ref>
<ref id="bibr18-0145721712464400">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lee</surname><given-names>IT</given-names></name>
<name><surname>Liu</surname><given-names>HC</given-names></name>
<name><surname>Liau</surname><given-names>YJ</given-names></name>
<name><surname>Lee</surname><given-names>WJ</given-names></name>
<name><surname>Huang</surname><given-names>CN</given-names></name>
<name><surname>Sheu</surname><given-names>WH</given-names></name>
</person-group>. <article-title>Improvement in health-related quality of life, independent of fasting glucose concentration, via insulin pen device in diabetic patients</article-title>. <source>J Eval Clin Pract</source>. <year>2009</year>;<volume>15</volume>(<issue>4</issue>):<fpage>699</fpage>-<lpage>703</lpage>.</citation>
</ref>
<ref id="bibr19-0145721712464400">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cemeroglu</surname><given-names>AP</given-names></name>
<name><surname>Stone</surname><given-names>R</given-names></name>
<name><surname>Kleis</surname><given-names>L</given-names></name>
<name><surname>Racine</surname><given-names>MS</given-names></name>
<name><surname>Postellon</surname><given-names>DC</given-names></name>
<name><surname>Wood</surname><given-names>MA</given-names></name>
</person-group>. <article-title>Use of a real-time continuous glucose monitoring system in children and young adults on insulin pump therapy: patients’ and caregivers’ perception of benefit</article-title>. <source>Pediatr Diabetes</source>. <year>2010</year>;<volume>11</volume>(<issue>3</issue>):<fpage>182</fpage>-<lpage>187</lpage>.</citation>
</ref>
<ref id="bibr20-0145721712464400">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Halford</surname><given-names>J</given-names></name>
<name><surname>Harris</surname><given-names>C</given-names></name>
</person-group>. <article-title>Determining clinical and psychological benefits and barriers with continuous glucose monitoring therapy</article-title>. <source>Diabetes Technol Ther</source>. <year>2010</year>;<volume>12</volume>(<issue>3</issue>):<fpage>201</fpage>-<lpage>205</lpage>.</citation>
</ref>
<ref id="bibr21-0145721712464400">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fritschi</surname><given-names>C</given-names></name>
<name><surname>Quinn</surname><given-names>L</given-names></name>
<name><surname>Penckofer</surname><given-names>S</given-names></name>
<name><surname>Surdyk</surname><given-names>PM</given-names></name>
</person-group>. <article-title>Continuous glucose monitoring: the experience of women with type 2 diabetes</article-title>. <source>Diabetes Educ</source>. <year>2010</year>;<volume>36</volume>(<issue>2</issue>):<fpage>250</fpage>-<lpage>257</lpage>.</citation>
</ref>
<ref id="bibr22-0145721712464400">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Logtenberg</surname><given-names>SJ</given-names></name>
<name><surname>Kleefstra</surname><given-names>N</given-names></name>
<name><surname>Houweling</surname><given-names>ST</given-names></name>
<name><surname>Groenier</surname><given-names>KH</given-names></name>
<name><surname>Gans</surname><given-names>RO</given-names></name>
<name><surname>Bilo</surname><given-names>HJ</given-names></name>
</person-group>. <article-title>Health-related quality of life, treatment satisfaction, and costs associated with intraperitoneal versus subcutaneous insulin administration in type 1 diabetes: a randomized controlled trial</article-title>. <source>Diabetes Care</source>. <year>2010</year>;<volume>33</volume>(<issue>6</issue>):<fpage>1169</fpage>-<lpage>1172</lpage>.</citation>
</ref>
<ref id="bibr23-0145721712464400">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Isla Pera</surname><given-names>P</given-names></name>
<name><surname>Moncho Vasallo</surname><given-names>J</given-names></name>
<name><surname>Torras Rabasa</surname><given-names>A</given-names></name>
<name><surname>Oppenheimer Salinas</surname><given-names>F</given-names></name>
<name><surname>Fernandez Cruz Perez</surname><given-names>L</given-names></name>
<name><surname>Ricart Brulles</surname><given-names>MJ</given-names></name>
</person-group>. <article-title>Quality of life in simultaneous pancreas-kidney transplant recipients</article-title>. <source>Clin Transplant</source>. <year>2009</year>;<volume>23</volume>(<issue>5</issue>):<fpage>600</fpage>-<lpage>605</lpage>.</citation>
</ref>
<ref id="bibr24-0145721712464400">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tharavanij</surname><given-names>T</given-names></name>
<name><surname>Betancourt</surname><given-names>A</given-names></name>
<name><surname>Messinger</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Improved long-term health-related quality of life after islet transplantation</article-title>. <source>Transplantation</source>. <year>2008</year>;<volume>86</volume>(<issue>9</issue>):<fpage>1161</fpage>-<lpage>1167</lpage>.</citation>
</ref>
<ref id="bibr25-0145721712464400">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Moon</surname><given-names>RJ</given-names></name>
<name><surname>Bascombe</surname><given-names>LA</given-names></name>
<name><surname>Holt</surname><given-names>RI</given-names></name>
</person-group>. <article-title>The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition and patient well-being</article-title>. <source>Diabetes Obes Metab</source>. <year>2007</year>;<volume>9</volume>(<issue>1</issue>):<fpage>143</fpage>-<lpage>145</lpage>.</citation>
</ref>
<ref id="bibr26-0145721712464400">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Best</surname><given-names>JH</given-names></name>
<name><surname>Rubin</surname><given-names>RR</given-names></name>
<name><surname>Peyrot</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>Weight-related quality of life, health utility, psychological well-being, and satisfaction with exenatide once weekly compared with sitagliptin or pioglitazone after 26 weeks of treatment</article-title>. <source>Diabetes Care</source>. <year>2011</year>;<volume>34</volume>(<issue>2</issue>):<fpage>314</fpage>-<lpage>319</lpage>.</citation>
</ref>
<ref id="bibr27-0145721712464400">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peyrot</surname><given-names>M</given-names></name>
<name><surname>Rubin</surname><given-names>RR</given-names></name>
<name><surname>Polonsky</surname><given-names>WH</given-names></name>
</person-group>. <article-title>Diabetes distress and its association with clinical outcomes in patients with type 2 diabetes treated with pramlintide as an adjunct to insulin therapy</article-title>. <source>Diabetes Technol Ther</source>. <year>2008</year>;<volume>10</volume>(<issue>6</issue>):<fpage>461</fpage>-<lpage>466</lpage>.</citation>
</ref>
<ref id="bibr28-0145721712464400">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Peyrot</surname><given-names>M</given-names></name>
<name><surname>Rubin</surname><given-names>RR</given-names></name>
<name><surname>Polonsky</surname><given-names>WH</given-names></name>
<name><surname>Best</surname><given-names>JH</given-names></name>
</person-group>. <article-title>Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs</article-title>. <source>Curr Med Res Opin</source>. <year>2010</year>;<volume>26</volume>(<issue>5</issue>):<fpage>1047</fpage>-<lpage>1054</lpage>.</citation>
</ref>
<ref id="bibr29-0145721712464400">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bode</surname><given-names>BW</given-names></name>
<name><surname>Testa</surname><given-names>MA</given-names></name>
<name><surname>Magwire</surname><given-names>M</given-names></name>
<etal/></person-group>. <article-title>Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetes</article-title>. <source>Diabetes Obes Metab</source>. <year>2010</year>;<volume>12</volume>(<issue>7</issue>):<fpage>604</fpage>-<lpage>612</lpage>.</citation>
</ref>
<ref id="bibr30-0145721712464400">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ushakova</surname><given-names>O</given-names></name>
<name><surname>Sokolovskaya</surname><given-names>V</given-names></name>
<name><surname>Morozova</surname><given-names>A</given-names></name>
<etal/></person-group>. <article-title>Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in Russia</article-title>. <source>Clin Ther</source>. <year>2007</year>;<volume>29</volume>(<issue>11</issue>):<fpage>2374</fpage>-<lpage>2384</lpage>.</citation>
</ref>
<ref id="bibr31-0145721712464400">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lingvay</surname><given-names>I</given-names></name>
<name><surname>Legendre</surname><given-names>JL</given-names></name>
<name><surname>Kaloyanova</surname><given-names>PF</given-names></name>
<name><surname>Zhang</surname><given-names>S</given-names></name>
<name><surname>Adams-Huet</surname><given-names>B</given-names></name>
<name><surname>Raskin</surname><given-names>P</given-names></name>
</person-group>. <article-title>Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better?</article-title> <source>Diabetes Care</source>. <year>2009</year>;<volume>32</volume>(<issue>10</issue>):<fpage>1789</fpage>-<lpage>1795</lpage>.</citation>
</ref>
<ref id="bibr32-0145721712464400">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Houlden</surname><given-names>R</given-names></name>
<name><surname>Ross</surname><given-names>S</given-names></name>
<name><surname>Harris</surname><given-names>S</given-names></name>
<name><surname>Yale</surname><given-names>JF</given-names></name>
<name><surname>Sauriol</surname><given-names>L</given-names></name>
<name><surname>Gerstein</surname><given-names>HC</given-names></name>
</person-group>. <article-title>Treatment satisfaction and quality of life using an early insulinization strategy with insulin glargine compared to an adjusted oral therapy in the management of type 2 diabetes: the Canadian INSIGHT Study</article-title>. <source>Diabetes Res Clin Pract</source>. <year>2007</year>;<volume>78</volume>(<issue>2</issue>):<fpage>254</fpage>-<lpage>258</lpage>.</citation>
</ref>
<ref id="bibr33-0145721712464400">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Vinik</surname><given-names>AI</given-names></name>
<name><surname>Zhang</surname><given-names>Q</given-names></name>
</person-group>. <article-title>Adding insulin glargine versus rosiglitazone: health-related quality-of-life impact in type 2 diabetes</article-title>. <source>Diabetes Care</source>. <year>2007</year>;<volume>30</volume>(<issue>4</issue>):<fpage>795</fpage>-<lpage>800</lpage>.</citation>
</ref>
<ref id="bibr34-0145721712464400">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Florez</surname><given-names>H</given-names></name>
<name><surname>Luo</surname><given-names>J</given-names></name>
<name><surname>Castillo-Florez</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes</article-title>. <source>Postgrad Med</source>. <year>2010</year>;<volume>122</volume>(<issue>2</issue>):<fpage>112</fpage>-<lpage>120</lpage>.</citation>
</ref>
<ref id="bibr35-0145721712464400">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pollack</surname><given-names>MF</given-names></name>
<name><surname>Purayidathil</surname><given-names>FW</given-names></name>
<name><surname>Bolge</surname><given-names>SC</given-names></name>
<name><surname>Williams</surname><given-names>SA</given-names></name>
</person-group>. <article-title>Patient-reported tolerability issues with oral antidiabetic agents: associations with adherence, treatment satisfaction and health-related quality of life</article-title>. <source>Diabetes Res Clin Pract</source>. <year>2010</year>;<volume>87</volume>(<issue>2</issue>):<fpage>204</fpage>-<lpage>210</lpage>.</citation>
</ref>
<ref id="bibr36-0145721712464400">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Masuda</surname><given-names>H</given-names></name>
<name><surname>Sakamoto</surname><given-names>M</given-names></name>
<name><surname>Irie</surname><given-names>J</given-names></name>
<etal/></person-group>. <article-title>Comparison of twice-daily injections of biphasic insulin lispro and basal-bolus therapy: glycaemic control and quality-of-life of insulin-naive type 2 diabetic patients</article-title>. <source>Diabetes Obes Metab</source>. <year>2008</year>;<volume>10</volume>(<issue>12</issue>):<fpage>1261</fpage>-<lpage>1265</lpage>.</citation>
</ref>
<ref id="bibr37-0145721712464400">
<label>37.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ishii</surname><given-names>H</given-names></name>
<name><surname>Anderson</surname><given-names>JH</given-names><suffix>Jr</suffix></name>
<name><surname>Yamamura</surname><given-names>A</given-names></name>
<name><surname>Takeuchi</surname><given-names>M</given-names></name>
<name><surname>Ikeda</surname><given-names>I</given-names></name>
</person-group>. <article-title>Improvement of glycemic control and quality-of-life by insulin lispro therapy: assessing benefits by ITR-QOL questionnaires</article-title>. <source>Diabetes Res Clin Pract</source>. <year>2008</year>;<volume>81</volume>(<issue>2</issue>):<fpage>169</fpage>-<lpage>178</lpage>.</citation>
</ref>
<ref id="bibr38-0145721712464400">
<label>38.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yamada</surname><given-names>S</given-names></name>
<name><surname>Watanabe</surname><given-names>M</given-names></name>
<name><surname>Kitaoka</surname><given-names>A</given-names></name>
<etal/></person-group>. <article-title>Switching from premixed human insulin to premixed insulin lispro: a prospective study comparing the effects on glucose control and quality of life</article-title>. <source>Intern Med</source>. <year>2007</year>;<volume>46</volume>(<issue>18</issue>):<fpage>1513</fpage>-<lpage>1517</lpage>.</citation>
</ref>
<ref id="bibr39-0145721712464400">
<label>39.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lowe</surname><given-names>J</given-names></name>
<name><surname>Linjawi</surname><given-names>S</given-names></name>
<name><surname>Mensch</surname><given-names>M</given-names></name>
<name><surname>James</surname><given-names>K</given-names></name>
<name><surname>Attia</surname><given-names>J</given-names></name>
</person-group>. <article-title>Flexible eating and flexible insulin dosing in patients with diabetes: results of an intensive self-management course</article-title>. <source>Diabetes Res Clin Pract</source>. <year>2008</year>;<volume>80</volume>(<issue>3</issue>):<fpage>439</fpage>-<lpage>443</lpage>.</citation>
</ref>
<ref id="bibr40-0145721712464400">
<label>40.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bendik</surname><given-names>CF</given-names></name>
<name><surname>Keller</surname><given-names>U</given-names></name>
<name><surname>Moriconi</surname><given-names>N</given-names></name>
<etal/></person-group>. <article-title>Training in flexible intensive insulin therapy improves quality of life, decreases the risk of hypoglycaemia and ameliorates poor metabolic control in patients with type 1 diabetes</article-title>. <source>Diabetes Res Clin Pract</source>. <year>2009</year>;<volume>83</volume>(<issue>3</issue>):<fpage>327</fpage>-<lpage>333</lpage>.</citation>
</ref>
<ref id="bibr41-0145721712464400">
<label>41.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Rossi</surname><given-names>MC</given-names></name>
<name><surname>Nicolucci</surname><given-names>A</given-names></name>
<name><surname>Di Bartolo</surname><given-names>P</given-names></name>
<etal/></person-group>. <article-title>Diabetes Interactive Diary: a new telemedicine system enabling flexible diet and insulin therapy while improving quality of life: an open-label, international, multicenter, randomized study</article-title>. <source>Diabetes Care</source>. <year>2010</year>;<volume>33</volume>(<issue>1</issue>):<fpage>109</fpage>-<lpage>115</lpage>.</citation>
</ref>
<ref id="bibr42-0145721712464400">
<label>42.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Speight</surname><given-names>J</given-names></name>
<name><surname>Amiel</surname><given-names>SA</given-names></name>
<name><surname>Bradley</surname><given-names>C</given-names></name>
<etal/></person-group>. <article-title>Long-term biomedical and psychosocial outcomes following DAFNE (Dose Adjustment For Normal Eating) structured education to promote intensive insulin therapy in adults with sub-optimally controlled type 1 diabetes</article-title>. <source>Diabetes Res Clin Pract</source>. <year>2010</year>;<volume>89</volume>(<issue>1</issue>):<fpage>22</fpage>-<lpage>29</lpage>.</citation>
</ref>
<ref id="bibr43-0145721712464400">
<label>43.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kempf</surname><given-names>K</given-names></name>
<name><surname>Kruse</surname><given-names>J</given-names></name>
<name><surname>Martin</surname><given-names>S</given-names></name>
</person-group>. <article-title>ROSSO-in-praxi: a self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus</article-title>. <source>Diabetes Technol Ther</source>. <year>2010</year>;<volume>12</volume>(<issue>7</issue>):<fpage>547</fpage>-<lpage>553</lpage>.</citation>
</ref>
<ref id="bibr44-0145721712464400">
<label>44.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bastiaens</surname><given-names>H</given-names></name>
<name><surname>Sunaert</surname><given-names>P</given-names></name>
<name><surname>Wens</surname><given-names>J</given-names></name>
<etal/></person-group>. <article-title>Supporting diabetes self-management in primary care: pilot-study of a group-based programme focusing on diet and exercise</article-title>. <source>Prim Care Diabetes</source>. <year>2009</year>;<volume>3</volume>(<issue>2</issue>):<fpage>103</fpage>-<lpage>109</lpage>.</citation>
</ref>
<ref id="bibr45-0145721712464400">
<label>45.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nansel</surname><given-names>TR</given-names></name>
<name><surname>Iannotti</surname><given-names>RJ</given-names></name>
<name><surname>Simons-Morton</surname><given-names>BG</given-names></name>
<etal/></person-group>. <article-title>Diabetes personal trainer outcomes: short-term and 1-year outcomes of a diabetes personal trainer intervention among youth with type 1 diabetes</article-title>. <source>Diabetes Care</source>. <year>2007</year>;<volume>30</volume>(<issue>10</issue>):<fpage>2471</fpage>-<lpage>2477</lpage>.</citation>
</ref>
<ref id="bibr46-0145721712464400">
<label>46.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tang</surname><given-names>TS</given-names></name>
<name><surname>Funnell</surname><given-names>MM</given-names></name>
<name><surname>Brown</surname><given-names>MB</given-names></name>
<name><surname>Kurlander</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Self-management support in “real-world” settings: an empowerment-based intervention</article-title>. <source>Patient Educ Couns</source>. <year>2010</year>;<volume>79</volume>(<issue>2</issue>):<fpage>178</fpage>-<lpage>184</lpage>.</citation>
</ref>
<ref id="bibr47-0145721712464400">
<label>47.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Chaveepojnkamjorn</surname><given-names>W</given-names></name>
<name><surname>Pichainarong</surname><given-names>N</given-names></name>
<name><surname>Schelp</surname><given-names>FP</given-names></name>
<name><surname>Mahaweerawat</surname><given-names>U</given-names></name>
</person-group>. <article-title>A randomized controlled trial to improve the quality of life of type 2 diabetic patients using a self-help group program</article-title>. <source>Southeast Asian J Trop Med Public Health</source>. <year>2009</year>;<volume>40</volume>(<issue>1</issue>):<fpage>169</fpage>-<lpage>176</lpage>.</citation>
</ref>
<ref id="bibr48-0145721712464400">
<label>48.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heisler</surname><given-names>M</given-names></name>
<name><surname>Vijan</surname><given-names>S</given-names></name>
<name><surname>Makki</surname><given-names>F</given-names></name>
<name><surname>Piette</surname><given-names>JD</given-names></name>
</person-group>. <article-title>Diabetes control with reciprocal peer support versus nurse care management: a randomized trial</article-title>. <source>Ann Intern Med</source>. <year>2010</year>;<volume>153</volume>(<issue>8</issue>):<fpage>507</fpage>-<lpage>515</lpage>.</citation>
</ref>
<ref id="bibr49-0145721712464400">
<label>49.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Comellas</surname><given-names>M</given-names></name>
<name><surname>Walker</surname><given-names>EA</given-names></name>
<name><surname>Movsas</surname><given-names>S</given-names></name>
<name><surname>Merkin</surname><given-names>S</given-names></name>
<name><surname>Zonszein</surname><given-names>J</given-names></name>
<name><surname>Strelnick</surname><given-names>H</given-names></name>
</person-group>. <article-title>Training community health promoters to implement diabetes self-management support programs for urban minority adults</article-title>. <source>Diabetes Educ</source>. <year>2010</year>;<volume>36</volume>(<issue>1</issue>):<fpage>141</fpage>-<lpage>151</lpage>.</citation>
</ref>
<ref id="bibr50-0145721712464400">
<label>50.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Amoako</surname><given-names>E</given-names></name>
<name><surname>Skelly</surname><given-names>AH</given-names></name>
</person-group>. <article-title>Managing uncertainty in diabetes: an intervention for older African American women</article-title>. <source>Ethn Dis</source>. <year>2007</year>;<volume>17</volume>(<issue>3</issue>):<fpage>515</fpage>-<lpage>521</lpage>.</citation>
</ref>
<ref id="bibr51-0145721712464400">
<label>51.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Amoako</surname><given-names>E</given-names></name>
<name><surname>Skelly</surname><given-names>AH</given-names></name>
<name><surname>Rossen</surname><given-names>EK</given-names></name>
</person-group>. <article-title>Outcomes of an intervention to reduce uncertainty among African American women with diabetes</article-title>. <source>West J Nurs Res</source>. <year>2008</year>;<volume>30</volume>(<issue>8</issue>):<fpage>928</fpage>-<lpage>942</lpage>.</citation>
</ref>
<ref id="bibr52-0145721712464400">
<label>52.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Gregg</surname><given-names>JA</given-names></name>
<name><surname>Callaghan</surname><given-names>GM</given-names></name>
<name><surname>Hayes</surname><given-names>SC</given-names></name>
<name><surname>Glenn-Lawson</surname><given-names>JL</given-names></name>
</person-group>. <article-title>Improving diabetes self-management through acceptance, mindfulness, and values: a randomized controlled trial</article-title>. <source>J Consult Clin Psychol</source>. <year>2007</year>;<volume>75</volume>(<issue>2</issue>):<fpage>336</fpage>-<lpage>343</lpage>.</citation>
</ref>
<ref id="bibr53-0145721712464400">
<label>53.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van Bastelaar</surname><given-names>KM</given-names></name>
<name><surname>Pouwer</surname><given-names>F</given-names></name>
<name><surname>Cuijpers</surname><given-names>P</given-names></name>
<name><surname>Riper</surname><given-names>H</given-names></name>
<name><surname>Snoek</surname><given-names>FJ</given-names></name>
</person-group>. <article-title>Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial</article-title>. <source>Diabetes Care</source>. <year>2011</year>;<volume>34</volume>(<issue>2</issue>):<fpage>320</fpage>-<lpage>325</lpage>.</citation>
</ref>
<ref id="bibr54-0145721712464400">
<label>54.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Salamon</surname><given-names>KS</given-names></name>
<name><surname>Hains</surname><given-names>AA</given-names></name>
<name><surname>Fleischman</surname><given-names>KM</given-names></name>
<name><surname>Davies</surname><given-names>WH</given-names></name>
<name><surname>Kichler</surname><given-names>J</given-names></name>
</person-group>. <article-title>Improving adherence in social situations for adolescents with type 1 diabetes mellitus (T1DM): a pilot study</article-title>. <source>Prim Care Diabetes</source>. <year>2010</year>;<volume>4</volume>(<issue>1</issue>):<fpage>47</fpage>-<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr55-0145721712464400">
<label>55.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Monaghan</surname><given-names>M</given-names></name>
<name><surname>Hilliard</surname><given-names>ME</given-names></name>
<name><surname>Cogen</surname><given-names>FR</given-names></name>
<name><surname>Streisand</surname><given-names>R</given-names></name>
</person-group>. <article-title>Supporting parents of very young children with type 1 diabetes: results from a pilot study</article-title>. <source>Patient Educ Couns</source>. <year>2011</year>;<volume>82</volume>(<issue>2</issue>):<fpage>271</fpage>-<lpage>274</lpage>.</citation>
</ref>
<ref id="bibr56-0145721712464400">
<label>56.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Lehmkuhl</surname><given-names>HD</given-names></name>
<name><surname>Storch</surname><given-names>EA</given-names></name>
<name><surname>Cammarata</surname><given-names>C</given-names></name>
<etal/></person-group>. <article-title>Telehealth behavior therapy for the management of type 1 diabetes in adolescents</article-title>. <source>J Diabetes Sci Technol</source>. <year>2010</year>;<volume>4</volume>(<issue>1</issue>):<fpage>199</fpage>-<lpage>208</lpage>.</citation>
</ref>
<ref id="bibr57-0145721712464400">
<label>57.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Snoek</surname><given-names>FJ</given-names></name>
<name><surname>van der Ven</surname><given-names>NC</given-names></name>
<name><surname>Twisk</surname><given-names>JW</given-names></name>
<etal/></person-group>. <article-title>Cognitive behavioural therapy (CBT) compared with blood glucose awareness training (BGAT) in poorly controlled type 1 diabetic patients: long-term effects on HbA moderated by depression: a randomized controlled trial</article-title>. <source>Diabet Med</source>. <year>2008</year>;<volume>25</volume>(<issue>11</issue>):<fpage>1337</fpage>-<lpage>1342</lpage>.</citation>
</ref>
<ref id="bibr58-0145721712464400">
<label>58.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van Bastelaar</surname><given-names>KM</given-names></name>
<name><surname>Pouwer</surname><given-names>F</given-names></name>
<name><surname>Cuijpers</surname><given-names>P</given-names></name>
<name><surname>Twisk</surname><given-names>JW</given-names></name>
<name><surname>Snoek</surname><given-names>FJ</given-names></name>
</person-group>. <article-title>Web-based cognitive behavioural therapy (W-CBT) for diabetes patients with co-morbid depression: design of a randomised controlled trial</article-title>. <source>BMC Psychiatry</source>. <year>2008</year>;<volume>8</volume>:<fpage>9</fpage>.</citation>
</ref>
<ref id="bibr59-0145721712464400">
<label>59.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Amsberg</surname><given-names>S</given-names></name>
<name><surname>Anderbro</surname><given-names>T</given-names></name>
<name><surname>Wredling</surname><given-names>R</given-names></name>
<etal/></person-group>. <article-title>A cognitive behavior therapy-based intervention among poorly controlled adult type 1 diabetes patients—a randomized controlled trial</article-title>. <source>Patient Educ Couns</source>. <year>2009</year>;<volume>77</volume>(<issue>1</issue>):<fpage>72</fpage>-<lpage>80</lpage>.</citation>
</ref>
<ref id="bibr60-0145721712464400">
<label>60.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>van der Feltz-Cornelis</surname><given-names>CM</given-names></name>
<name><surname>Nuyen</surname><given-names>J</given-names></name>
<name><surname>Stoop</surname><given-names>C</given-names></name>
<etal/></person-group>. <article-title>Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis</article-title>. <source>Gen Hosp Psychiatry</source>. <year>2010</year>;<volume>32</volume>(<issue>4</issue>):<fpage>380</fpage>-<lpage>395</lpage>.</citation>
</ref>
<ref id="bibr61-0145721712464400">
<label>61.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Harris</surname><given-names>MA</given-names></name>
<name><surname>Freeman</surname><given-names>KA</given-names></name>
<name><surname>Beers</surname><given-names>M</given-names></name>
</person-group>. <article-title>Family therapy for adolescents with poorly controlled diabetes: initial test of clinical significance</article-title>. <source>J Pediatr Psychol</source>. <year>2009</year>;<volume>34</volume>(<issue>10</issue>):<fpage>1097</fpage>-<lpage>1107</lpage>.</citation>
</ref>
<ref id="bibr62-0145721712464400">
<label>62.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wysocki</surname><given-names>T</given-names></name>
<name><surname>Harris</surname><given-names>MA</given-names></name>
<name><surname>Buckloh</surname><given-names>LM</given-names></name>
<etal/></person-group>. <article-title>Effects of behavioral family systems therapy for diabetes on adolescents’ family relationships, treatment adherence, and metabolic control</article-title>. <source>J Pediatr Psychol</source>. <year>2006</year>;<volume>31</volume>(<issue>9</issue>):<fpage>928</fpage>-<lpage>938</lpage>.</citation>
</ref>
<ref id="bibr63-0145721712464400">
<label>63.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wysocki</surname><given-names>T</given-names></name>
<name><surname>Harris</surname><given-names>MA</given-names></name>
<name><surname>Buckloh</surname><given-names>LM</given-names></name>
<etal/></person-group>. <article-title>Randomized, controlled trial of behavioral family systems therapy for diabetes: maintenance and generalization of effects on parent-adolescent communication</article-title>. <source>Behav Ther</source>. <year>2008</year>;<volume>39</volume>(<issue>1</issue>):<fpage>33</fpage>-<lpage>46</lpage>.</citation>
</ref>
<ref id="bibr64-0145721712464400">
<label>64.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Echeverry</surname><given-names>D</given-names></name>
<name><surname>Duran</surname><given-names>P</given-names></name>
<name><surname>Bonds</surname><given-names>C</given-names></name>
<name><surname>Lee</surname><given-names>M</given-names></name>
<name><surname>Davidson</surname><given-names>MB</given-names></name>
</person-group>. <article-title>Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial</article-title>. <source>Diabetes Care</source>. <year>2009</year>;<volume>32</volume>(<issue>12</issue>):<fpage>2156</fpage>-<lpage>2160</lpage>.</citation>
</ref>
<ref id="bibr65-0145721712464400">
<label>65.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Williams</surname><given-names>MM</given-names></name>
<name><surname>Clouse</surname><given-names>RE</given-names></name>
<name><surname>Nix</surname><given-names>BD</given-names></name>
<etal/></person-group>. <article-title>Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes</article-title>. <source>Diabetes Care</source>. <year>2007</year>;<volume>30</volume>(<issue>4</issue>):<fpage>801</fpage>-<lpage>806</lpage>.</citation>
</ref>
<ref id="bibr66-0145721712464400">
<label>66.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Choi</surname><given-names>BCK</given-names></name>
<name><surname>Pak</surname><given-names>AWP</given-names></name>
</person-group>. <article-title>Multidisciplinarity, interdisciplinarity, and transdisciplinarity in health research, services, education and policy, 2: promotors, barriers, and strategies of enhancement</article-title>. <source>Clin Invest Med</source>. <year>2007</year>;<volume>30</volume>(<issue>6</issue>):<fpage>E224</fpage>-<lpage>E232</lpage>.</citation>
</ref>
<ref id="bibr67-0145721712464400">
<label>67.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Simson</surname><given-names>U</given-names></name>
<name><surname>Nawarotzky</surname><given-names>U</given-names></name>
<name><surname>Friese</surname><given-names>G</given-names></name>
<etal/></person-group>. <article-title>Psychotherapy intervention to reduce depressive symptoms in patients with diabetic foot syndrome</article-title>. <source>Diabet Med</source>. <year>2008</year>;<volume>25</volume>(<issue>2</issue>):<fpage>206</fpage>-<lpage>212</lpage>.</citation>
</ref>
<ref id="bibr68-0145721712464400">
<label>68.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Menard</surname><given-names>J</given-names></name>
<name><surname>Payette</surname><given-names>H</given-names></name>
<name><surname>Dubuc</surname><given-names>N</given-names></name>
<name><surname>Baillargeon</surname><given-names>JP</given-names></name>
<name><surname>Maheux</surname><given-names>P</given-names></name>
<name><surname>Ardilouze</surname><given-names>JL</given-names></name>
</person-group>. <article-title>Quality of life in type 2 diabetes patients under intensive multitherapy</article-title>. <source>Diabetes Metab</source>. <year>2007</year>;<volume>33</volume>(<issue>1</issue>):<fpage>54</fpage>-<lpage>60</lpage>.</citation>
</ref>
<ref id="bibr69-0145721712464400">
<label>69.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Benhamou</surname><given-names>PY</given-names></name>
<name><surname>Melki</surname><given-names>V</given-names></name>
<name><surname>Boizel</surname><given-names>R</given-names></name>
<etal/></person-group>. <article-title>One-year efficacy and safety of Web-based follow-up using cellular phone in type 1 diabetic patients under insulin pump therapy: the PumpNet study</article-title>. <source>Diabetes Metab</source>. <year>2007</year>;<volume>33</volume>(<issue>3</issue>):<fpage>220</fpage>-<lpage>226</lpage>.</citation>
</ref>
<ref id="bibr70-0145721712464400">
<label>70.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Beever</surname><given-names>R</given-names></name>
</person-group>. <article-title>The effects of repeated thermal therapy on quality of life in patients with type II diabetes mellitus</article-title>. <source>J Altern Complement Med</source>. <year>2010</year>;<volume>16</volume>(<issue>6</issue>):<fpage>677</fpage>-<lpage>681</lpage>.</citation>
</ref>
<ref id="bibr71-0145721712464400">
<label>71.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Skoro-Kondza</surname><given-names>L</given-names></name>
<name><surname>Tai</surname><given-names>SS</given-names></name>
<name><surname>Gadelrab</surname><given-names>R</given-names></name>
<name><surname>Drincevic</surname><given-names>D</given-names></name>
<name><surname>Greenhalgh</surname><given-names>T</given-names></name>
</person-group>. <article-title>Community based yoga classes for type 2 diabetes: an exploratory randomised controlled trial</article-title>. <source>BMC Health Serv Res</source>. <year>2009</year>;<volume>9</volume>:<fpage>33</fpage>.</citation>
</ref>
<ref id="bibr72-0145721712464400">
<label>72.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Katon</surname><given-names>WJ</given-names></name>
<name><surname>Russo</surname><given-names>JE</given-names></name>
<name><surname>Von Korff</surname><given-names>M</given-names></name>
<name><surname>Lin</surname><given-names>EH</given-names></name>
<name><surname>Ludman</surname><given-names>E</given-names></name>
<name><surname>Ciechanowski</surname><given-names>PS</given-names></name>
</person-group>. <article-title>Long-term effects on medical costs of improving depression outcomes in patients with depression and diabetes</article-title>. <source>Diabetes Care</source>. <year>2008</year>;<volume>31</volume>(<issue>6</issue>):<fpage>1155</fpage>-<lpage>1159</lpage>.</citation>
</ref>
<ref id="bibr73-0145721712464400">
<label>73.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Simon</surname><given-names>GE</given-names></name>
<name><surname>Katon</surname><given-names>WJ</given-names></name>
<name><surname>Lin</surname><given-names>EH</given-names></name>
<etal/></person-group>. <article-title>Cost-effectiveness of systematic depression treatment among people with diabetes mellitus</article-title>. <source>Arch Gen Psychiatry</source>. <year>2007</year>;<volume>64</volume>(<issue>1</issue>):<fpage>65</fpage>-<lpage>72</lpage>.</citation>
</ref>
<ref id="bibr74-0145721712464400">
<label>74.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ell</surname><given-names>K</given-names></name>
<name><surname>Aranda</surname><given-names>MP</given-names></name>
<name><surname>Xie</surname><given-names>B</given-names></name>
<name><surname>Lee</surname><given-names>PJ</given-names></name>
<name><surname>Chou</surname><given-names>CP</given-names></name>
</person-group>. <article-title>Collaborative depression treatment in older and younger adults with physical illness: pooled comparative analysis of three randomized clinical trials</article-title>. <source>Am J Geriatr Psychiatry</source>. <year>2010</year>;<volume>18</volume>(<issue>6</issue>):<fpage>520</fpage>-<lpage>530</lpage>.</citation>
</ref>
<ref id="bibr75-0145721712464400">
<label>75.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ell</surname><given-names>K</given-names></name>
<name><surname>Katon</surname><given-names>W</given-names></name>
<name><surname>Xie</surname><given-names>B</given-names></name>
<etal/></person-group>. <article-title>Collaborative care management of major depression among low-income, predominantly Hispanic subjects with diabetes: a randomized controlled trial</article-title>. <source>Diabetes Care</source>. <year>2010</year>;<volume>33</volume>(<issue>4</issue>):<fpage>706</fpage>-<lpage>713</lpage>.</citation>
</ref>
<ref id="bibr76-0145721712464400">
<label>76.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Goss</surname><given-names>PW</given-names></name>
<name><surname>Paterson</surname><given-names>MA</given-names></name>
<name><surname>Renalson</surname><given-names>J</given-names></name>
</person-group>. <article-title>A “radical” new rural model for pediatric diabetes care</article-title>. <source>Pediatr Diabetes</source>. <year>2010</year>;<volume>11</volume>(<issue>5</issue>):<fpage>296</fpage>-<lpage>304</lpage>.</citation>
</ref>
<ref id="bibr77-0145721712464400">
<label>77.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Knight</surname><given-names>DE</given-names></name>
<name><surname>Draeger</surname><given-names>RW</given-names></name>
<name><surname>Heaton</surname><given-names>PC</given-names></name>
<name><surname>Patel</surname><given-names>NC</given-names></name>
</person-group>. <article-title>Pharmacist screening for depression among patients with diabetes in an urban primary care setting</article-title>. <source>J Am Pharm Assoc</source>. <year>2008</year>;<volume>48</volume>(<issue>4</issue>):<fpage>518</fpage>-<lpage>521</lpage>.</citation>
</ref>
<ref id="bibr78-0145721712464400">
<label>78.</label>
<citation citation-type="book"><collab>World Health Organization</collab>. <source>Adherence to Long-Term Therapies: Evidence for Action</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2003</year>.</citation>
</ref>
<ref id="bibr79-0145721712464400">
<label>79.</label>
<citation citation-type="journal"><collab>California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes</collab>. <article-title>Guidelines for improving the care of the older person with diabetes mellitus</article-title>. <source>J Am Geriatr Soc</source>. <year>2003</year>;<volume>51</volume>(<issue>5</issue>):<fpage>S265</fpage>-<lpage>S280</lpage>.</citation>
</ref>
<ref id="bibr80-0145721712464400">
<label>80.</label>
<citation citation-type="journal"><collab>Standards of medical care in diabetes—2011</collab>. <source>Diabetes Care</source>. <year>2011</year>;<volume>34</volume>(<supplement>suppl 1</supplement>):<fpage>S11</fpage>-<lpage>S61</lpage>.</citation>
</ref>
<ref id="bibr81-0145721712464400">
<label>81.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Feil</surname><given-names>DG</given-names></name>
<name><surname>Rajan</surname><given-names>M</given-names></name>
<name><surname>Soroka</surname><given-names>O</given-names></name>
<name><surname>Tseng</surname><given-names>CL</given-names></name>
<name><surname>Miller</surname><given-names>DR</given-names></name>
<name><surname>Pogach</surname><given-names>LM</given-names></name>
</person-group>. <article-title>Risk of hypoglycemia in older veterans with dementia and cognitive impairment: implications for practice and policy</article-title>. <source>J Am Geriatr Soc</source>. <year>2011</year>;<volume>59</volume>(<issue>12</issue>):<fpage>2263</fpage>-<lpage>2272</lpage>.</citation>
</ref>
<ref id="bibr82-0145721712464400">
<label>82.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Fisher</surname><given-names>EB</given-names></name>
<name><surname>Thorpe</surname><given-names>C</given-names></name>
<name><surname>Brownson</surname><given-names>CA</given-names></name>
<etal/></person-group>. <source>Healthy Coping in Diabetes: A Guide for Program Development and Implementation</source>. <publisher-loc>Princeton, NJ</publisher-loc>: <publisher-name>Diabetes Initiative National Program Office (NPO)</publisher-name>; <month>August</month> <year>2008</year>.</citation>
</ref>
<ref id="bibr83-0145721712464400">
<label>83.</label>
<citation citation-type="book"><collab>American Psychiatric Association</collab>. <source>Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Psychiatric Association</publisher-name>; <year>2000</year>.</citation>
</ref>
<ref id="bibr84-0145721712464400">
<label>84.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Cohen</surname><given-names>S</given-names></name>
<name><surname>Kamarck</surname><given-names>T</given-names></name>
<name><surname>Mermelstein</surname><given-names>R</given-names></name>
</person-group>. <article-title>A global measure of perceived stress</article-title>. <source>J Health Soc Behav</source>. <year>1983</year>;<volume>24</volume>:<fpage>386</fpage>-<lpage>396</lpage>.</citation>
</ref>
<ref id="bibr85-0145721712464400">
<label>85.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Polonsky</surname><given-names>WH</given-names></name>
<name><surname>Anderson</surname><given-names>BJ</given-names></name>
<name><surname>Lohrer</surname><given-names>PA</given-names></name>
<etal/></person-group>. <article-title>Assessment of diabetes-related distress</article-title>. <source>Diabetes Care</source>. <year>1995</year>;<volume>18</volume>(<issue>6</issue>):<fpage>754</fpage>-<lpage>760</lpage>.</citation>
</ref>
<ref id="bibr86-0145721712464400">
<label>86.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Polonsky</surname><given-names>WH</given-names></name>
<name><surname>Fisher</surname><given-names>L</given-names></name>
<name><surname>Earles</surname><given-names>J</given-names></name>
<etal/></person-group>. <article-title>Assessing psychosocial distress in diabetes: development of the diabetes distress scale</article-title>. <source>Diabetes Care</source>. <year>2005</year>;<volume>28</volume>(<issue>3</issue>):<fpage>626</fpage>-<lpage>631</lpage>.</citation>
</ref>
<ref id="bibr87-0145721712464400">
<label>87.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Welch</surname><given-names>G</given-names></name>
<name><surname>Dunn</surname><given-names>SM</given-names></name>
<name><surname>Beeney</surname><given-names>LJ</given-names></name>
</person-group>. <article-title>The ATT39: a measure of psychological adjustment to diabetes</article-title>. In: <person-group person-group-type="editor">
<name><surname>Bradley</surname><given-names>C</given-names></name>
</person-group>, ed. <source>Handbook of Psychology and Diabetes</source>. <publisher-loc>Chur, Switzerland</publisher-loc>: <publisher-name>Harwood Academic Publishers</publisher-name>; <volume>1994</volume>:<fpage>223</fpage>-<lpage>245</lpage>.</citation>
</ref>
<ref id="bibr88-0145721712464400">
<label>88.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Campbell</surname><given-names>WH</given-names></name>
<name><surname>Anderson</surname><given-names>WK</given-names></name>
<name><surname>Burckart</surname><given-names>GJ</given-names></name>
<etal/></person-group>. <article-title>Institutional and faculty roles and responsibilities in the emerging environment of university-wide interdisciplinary research structures: report of the 2001-2002 Research and Graduate Affairs Committee</article-title>. <source>Am J Pharm Educ</source>. <year>2002</year>;<volume>66</volume>:28s-33s.</citation>
</ref>
<ref id="bibr89-0145721712464400">
<label>89.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Utz</surname><given-names>SW</given-names></name>
<name><surname>Williams</surname><given-names>IC</given-names></name>
<name><surname>Jones</surname><given-names>R</given-names></name>
<etal/></person-group>. <article-title>Culturally tailored intervention for rural African Americans with type 2 diabetes</article-title>. <source>Diabetes Educ</source>. <year>2008</year>;<volume>34</volume>(<issue>5</issue>):<fpage>854</fpage>-<lpage>865</lpage>.</citation>
</ref>
<ref id="bibr90-0145721712464400">
<label>90.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ismail</surname><given-names>K</given-names></name>
<name><surname>Maissi</surname><given-names>E</given-names></name>
<name><surname>Thomas</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with type 1 diabetes mellitus with persistent sub-optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study</article-title>. <source>Health Technol Assess</source>. <year>2010</year>;<volume>14</volume>(<issue>22</issue>):<fpage>1</fpage>-<lpage>101</lpage>, <fpage>iii</fpage>-<lpage>iv</lpage>.</citation>
</ref>
<ref id="bibr91-0145721712464400">
<label>91.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Nansel</surname><given-names>TR</given-names></name>
<name><surname>Anderson</surname><given-names>BJ</given-names></name>
<name><surname>Laffel</surname><given-names>LM</given-names></name>
<etal/></person-group>. <article-title>A multisite trial of a clinic-integrated intervention for promoting family management of pediatric type 1 diabetes: feasibility and design</article-title>. <source>Pediatr Diabetes</source>. <year>2009</year>;<volume>10</volume>(<issue>2</issue>):<fpage>105</fpage>-<lpage>115</lpage>.</citation>
</ref>
<ref id="bibr92-0145721712464400">
<label>92.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ellis</surname><given-names>DA</given-names></name>
<name><surname>Yopp</surname><given-names>J</given-names></name>
<name><surname>Templin</surname><given-names>T</given-names></name>
<etal/></person-group>. <article-title>Family mediators and moderators of treatment outcomes among youths with poorly controlled type 1 diabetes: results from a randomized controlled trial</article-title>. <source>J Pediatr Psychol</source>. <year>2007</year>;<volume>32</volume>(<issue>2</issue>):<fpage>194</fpage>-<lpage>205</lpage>.</citation>
</ref>
<ref id="bibr93-0145721712464400">
<label>93.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ellis</surname><given-names>D</given-names></name>
<name><surname>Naar-King</surname><given-names>S</given-names></name>
<name><surname>Templin</surname><given-names>T</given-names></name>
<etal/></person-group>. <article-title>Multisystemic therapy for adolescents with poorly controlled type 1 diabetes: reduced diabetic ketoacidosis admissions and related costs over 24 months</article-title>. <source>Diabetes Care</source>. <year>2008</year>;<volume>31</volume>(<issue>9</issue>):<fpage>1746</fpage>-<lpage>1747</lpage>.</citation>
</ref>
<ref id="bibr94-0145721712464400">
<label>94.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ellis</surname><given-names>DA</given-names></name>
<name><surname>Templin</surname><given-names>T</given-names></name>
<name><surname>Naar-King</surname><given-names>S</given-names></name>
<etal/></person-group>. <article-title>Multisystemic therapy for adolescents with poorly controlled type I diabetes: stability of treatment effects in a randomized controlled trial</article-title>. <source>J Consult Clin Psychol</source>. <year>2007</year>;<volume>75</volume>(<issue>1</issue>):<fpage>168</fpage>-<lpage>174</lpage>.</citation>
</ref>
<ref id="bibr95-0145721712464400">
<label>95.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ellis</surname><given-names>DA</given-names></name>
<name><surname>Naar-King</surname><given-names>S</given-names></name>
<name><surname>Templin</surname><given-names>T</given-names></name>
<name><surname>Frey</surname><given-names>MA</given-names></name>
<name><surname>Cunningham</surname><given-names>PB</given-names></name>
</person-group>. <article-title>Improving health outcomes among youth with poorly controlled type I diabetes: the role of treatment fidelity in a randomized clinical trial of multisystemic therapy</article-title>. <source>J Fam Psychol</source>. <year>2007</year>;<volume>21</volume>(<issue>3</issue>):<fpage>363</fpage>-<lpage>371</lpage>.</citation>
</ref>
<ref id="bibr96-0145721712464400">
<label>96.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Wysocki</surname><given-names>T</given-names></name>
<name><surname>Harris</surname><given-names>MA</given-names></name>
<name><surname>Buckloh</surname><given-names>LM</given-names></name>
<etal/></person-group>. <article-title>Randomized trial of behavioral family systems therapy for diabetes: maintenance of effects on diabetes outcomes in adolescents</article-title>. <source>Diabetes Care</source>. <year>2007</year>;<volume>30</volume>(<issue>3</issue>):<fpage>555</fpage>-<lpage>560</lpage>.</citation>
</ref>
<ref id="bibr97-0145721712464400">
<label>97.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Jones</surname><given-names>LE</given-names></name>
<name><surname>Turvey</surname><given-names>C</given-names></name>
<name><surname>Torner</surname><given-names>JC</given-names></name>
<name><surname>Doebbeling</surname><given-names>CC</given-names></name>
</person-group>. <article-title>Nonadherence to depression treatment guidelines among veterans with diabetes mellitus</article-title>. <source>Am J Manag Care</source>. <year>2006</year>;<volume>12</volume>(<issue>12</issue>):<fpage>701</fpage>-<lpage>710</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>